1 APRIL – 30 JUNE, 2016            ·  The Group’s net sales increased by 23.2 percent to SEK 122.2 million (99.2). Excluding currency effects, sales increased by 24.8 percent. ·  The gross profit margin was 53.5 percent (53.0). ·  Operating profit amounted to SEK 0.3 million, against a year-earlier loss of SEK 1.7 million. ·  The loss after tax was SEK 2.2 million, against a year-earlier loss of SEK 2.3 million. ·  Earnings per share before dilution amounted to SEK –0.09 (–0.04) and earnings per share after dilution amounted to SEK –0.08 (–0.04). 1 JANUARY – 30 JUNE, 2016 ·  The Group’s net sales increased by 21.7 percent to SEK 280.2 million (230.3). Excluding currency effects, sales increased by 22.4 percent. ·  The gross profit margin was 51.5 percent (53.4). ·  Operating profit amounted to SEK 14.2 million (11.2). ·  Profit after tax amounted to SEK 4.3 million (12.6). ·  Earnings per share before dilution amounted to SEK 0.20 (0.57) and earnings per share after dilution amounted to SEK 0.20 (0.57). QUOTE FROM THE CEO                          “During the quarter we strengthened our position as planned in sports and sports apparel, especially in our male target market. In one of our consumer surveys, 25 percent of respondents said they would buy athletic apparel from us, and in both the Netherlands and Norway we ranked fourth among men. We succeeded at the same time in maintaining our strong position in men’s underwear, where we remain number 1 in all our priority markets,” said CEO Henrik Bunge.  For further information, please contact:Henrik Bunge, CEO, telephone +46 8 506 33 700Daniel Grohman, CFO, telephone +46 8 506 33 700 Björn Borg is required to make public the information in this interim report in accordance with the Securities Market Act.The information was released for publication on August 19, 2016 at 7:30 pm (CET).

Canadian medical technology company LABORIE to become new subsidiary

Patricia Industries, a part of Investor AB, has signed an agreement with Audax Private Equity to acquire the Canadian medical technology company LABORIE, which focuses on the diagnosis and treatment of urologic and gastrointestinal disorders that affect the daily lives of millions. LABORIE was founded in 1967 and has grown organically and through acquisitions from a leading manufacturer of capital equipment for urodynamic testing into a fully-integrated medical device company with a market-leading position in urology and a rapidly growing gastroenterology business. LABORIE has an attractive, asset-light business model with a high share of its revenue derived from recurring sales of proprietary consumables. LABORIE’s global manufacturing, development and commercialization capabilities create a solid platform for growth through organic and non-organic expansion in core and adjacent markets, new geographies and further expansion beyond diagnostics into therapeutic products. LABORIE will continue to be run by its current management team, which will remain part-owners of the company. LABORIE will be the most recent addition to the Patricia Industries portfolio of high-quality growth companies, whose other healthcare holdings include Mölnlycke Health Care, Permobil, Aleris and BraunAbility. Fiscal year 2016 (ending March) sales were USD 117 m. with strong profitability. Additional financial information about LABORIE, including the acquisition price, will be disclosed upon completion of the acquisition. “LABORIE will be a strong addition to Patricia Industries and marks another step in our strategy to continue to build our portfolio of wholly-owned subsidiaries in the Nordics and in North America”, comments Investor CEO Johan Forssell. The acquisition of LABORIE is Patricia Industries’ first Canadian acquisition and the second in North America since the inception of Patricia Industries in 2015. LABORIE will be a new subsidiary managed out of the New York office. “LABORIE has successfully developed into a high-quality and highly regarded provider of diagnostics products that help a vast number of people improve their daily lives, and its culture and values fit very well with those of Patricia Industries and Investor. Drawing from our experience and global network within healthcare products and services, we believe that Patricia Industries is well-positioned to support LABORIE in its continued progress in a number of areas. We look forward to working together with LABORIE’s dedicated management and employees to advance the company’s position further, to the benefit of its customers, employees and owners”, comments Börje Ekholm, CEO of Patricia Industries. “We are excited to partner with Patricia Industries for the next phase of our growth”, comments LABORIE President and CEO Brian Ellacott. “LABORIE is the global leader in improving quality of life for patients suffering from urologic and gastroenterology disorders. This investment will allow us to continue to expand our global footprint as well as develop and bring to market innovative new products that will improve outcomes for patients.” The acquisition is subject to approval by the relevant competition authorities. Closing is expected during the third quarter 2016. Patricia Industries, a part of Investor AB, makes control investments in best-in-class companies with strong market positions, brands and corporate cultures within industries positioned for secular growth. Our ambition is to be the sole owner of our companies, together with strong management teams and boards. We invest with an indefinite holding period, and focus on building durable value and capturing organic and non-organic growth opportunities. LABORIE is an industry-leading manufacturer and supplier of pelvic health and gastrointestinal equipment and consumables. Since its founding in 1967, LABORIE has been committed to delivering innovative, complete solutions that provide better diagnostics and treatment outcomes to patients worldwide. LABORIE is a portfolio company of Audax Private Equity. Since its founding in 1999, Audax Private Equity has been focused on building leading middle market companies. Audax has invested over $3.5 billion in 99 platform and 498 add-on companies. Through its disciplined Buy & Build approach, Audax seeks to help platform companies execute add-on acquisitions that fuel revenue growth, optimize operations, and significantly increase equity value. Audax Private Equity is an integral part of Audax Group, an alternative asset management firm specializing in investments in middle market companies. With offices in Boston, New York, and Menlo Park, Audax Group has over $10 billion in assets under management across its Private Equity, Mezzanine, and Senior Debt businesses. For more information, visit the Audax Group website

Geographical expansion

Second quarter: April-June 2016 · Operating revenue amounted to SEK 1,534 M (1,379), an increase of 11% or SEK 155 M. Acquisitions contributed SEK 144 M to revenue. Revenue increased organically by SEK 20 M, or 1.5%. In constant currency, revenue increased organically by 2%. · Operating profit was SEK 56 M (24 incl. capital loss of SEK 32 M on disposal of Villa Skaar). Acquisitions contributed SEK 17 M to operating profit. Operating profit was negatively affected by increased costs for higher social security contributions of SEK 19 M, acquisition costs of SEK 15 M (1) and non-recurring costs for the company’s IPO of SEK 2 M (0). The operating margin for the quarter was 3.7% (1.7).    · Net profit after tax for the period was SEK 36 M (-7). · Earnings per share for the period before and after dilution were SEK 0.67 SEK (-1.08). · Operating cash flow was SEK 29 M (85). Interim period January-June 2016 · Operating revenue increased 10% to SEK 3,005 M (2,730), an increase of SEK 275 M. Acquisitions contributed SEK 232 M to revenue. Divested companies contributed SEK 20 M last year. Organically, revenue increased by SEK 64 M or 2.3%. In constant currency, revenue increased organically by 2.9%. · Operating profit was SEK 98 M (108), a decrease of SEK 10 M. Acquisitions contributed SEK 28 M to operating profit. Operating profit was negatively affected by increased costs for higher social security contributions amounting to SEK 30 M and costs for the company’s IPO amounting to SEK 40 M (0). Operating profit adjusted for IPO expenses amounted to SEK 137 M (142), an adjusted operating margin of 4.6% (5.2).  · Net profit after tax for the period was SEK 20 M (36). Costs associated with refinancing of SEK 42 M were charged to profit before tax for the period. · Earnings per share for the period before and after dilution were SEK -0.04 SEK (-0.15). · Operating cash flow was SEK 59 M (160).   Events during the second quarter · Acquisitions1) Humana expands into Finland by acquiring Arjessa Oy.  Arjessa’s revenue for 2015 amounted to SEK 299 M and operating profit before goodwill amortisation was SEK 29 M. The preliminary purchase price amounts to SEK 271 M, which includes an estimated SEK 1 M earn-out payment.2) Humana strengthens its position in Norway by acquiring Kvæfjord Opplevelse og Avlastning AS (KOA Group).In 2015, revenue in the KOA Group amounted to SEK 203 M and operating profit was SEK 30 M. The preliminary purchase price amounts to SEK 227 M, which includes an estimated SEK 18 M earn-out payment based on 2016 earnings. Presentation of second quarter report today at 09:00 CETTo participate in the conference call, and thereby be able to ask questions, please call one of the following numbers: SE: +46 8 566 426 63 or UK: +44 203 008 98 01The presentation material will be published before the conference starts on Humana’s website, under Investor Relations. This information is such that Humana AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 08:00 CET on August 19, 2016. For more information, please contact:Rasmus Nerman, CEO, +46 (0)70-828 1860, rasmus.nerman@humana.seUlf Bonnevier, CFO, +46 (0)70-164 73 17, ulf.bonnevier@humana.seCecilia Lannebo, Head of Investor Relations, +46 (0)72-220 82 77,

Eltel Group: Interim Report January–June 2016

January–June 2016 · Net sales amounted to EUR 656.6 million (546.8), up 23.0% in local currencies, organic net sales increased by 3.2%* · Operative EBITA amounted to EUR 8.9 million (19.2) or 1.4% of net sales (3.5) · No items affecting comparability (-2.6) · EBITA amounted to EUR 8.9 million (16.7) or 1.4% of net sales (3.0) · EBIT amounted to EUR 1.7 million (10.5) · Net financial expenses decreased to EUR -6.1 million (-9.7) · The net result amounted to EUR -3.7 million (0.7) · Earnings per share was EUR -0.07 (0.01) · Operative cash flow was negative at EUR 53.1 million (-37.2), cash conversion was 68.8% on a rolling 12-month basis April–June 2016 · Net sales amounted to EUR 369.0 million (307.8), up 22.9% in local currencies, organic net sales increased by 3.5%* · Operative EBITA amounted to EUR 5.7 million (13.9) or 1.6% of net sales (4.5) · EBITA amounted to EUR 5.7 million (14.0) or 1.6% of net sales (4.5) · EBIT amounted to EUR 2.1 million (10.9) · Net financial expenses amounted to EUR -2.4 million (-1.8) · The net result amounted to EUR -0.1 million (8.3) · Earnings per share was EUR -0.01 (0.13) · Operative cash flow was negative at EUR 15.7 million (+22.7) Unless otherwise stated, figures in brackets refer to the same period in the previous year* Organic net sales excludes Norwegian Communication business and the Sønnico and Vete acquisitions in 2015 and U-SERV acquisition in 2016, and are presented using comparable exchange rates. Comments by the CEO Strong growth, but isolated performance issues affected profitability Eltel continued to show very strong growth in the second quarter 2016. The more than 20% increase in sales was primarily driven by the past year’s acquisitions, but also by solid organic growth. Regarding new orders, it is very encouraging that these also include contracts in the power transmission sector both in the Nordics and the UK. The Communication segment continued to show a solid performance with good margin development and strong growth, even excluding the consolidated Eltel Sønnico business. However, Group profitability for the second quarter was negatively affected by a EUR 10 million provision related to the execution of a challenging rail project in Norway, as previously announced. This event is totally unacceptable and Eltel is now taking immediate corrective actions to rectify the situation and to ensure that it does not happen again. The main root cause for the poor execution is unsatisfactory technical quality in the delivery of this project resulting in additional significant amount of corrective works. Currently, we are putting maximum effort into making necessary improvements, including additional quality and performance audits as well as managerial and process changes. The quarter was also impacted by performance issues in certain African power projects, effects from the lower order intake in the power transmission business over the last twelve months and continued impact from the other challenging Norwegian rail project. In parallel, we have initiated further Group initiatives with a very strong focus on operational efficiency in terms of specialisation and sharing of best practices. As a very good example of this, we have gradually changed the organisational structure of the fibre business to better support the current strong market demand. Our ongoing Group Shared Services programme – a two-year initiative to centralise our support functions and utilise best practice and add efficiency – is another good example of improvements based on The Eltel Way concept. Our cash flow was negative during the quarter as a consequence of higher net working capital and made acquisitions. In the short term, cash flow is expected to continue to be weak compared to the good performance last year due to challenges mentioned above. However, we still see that our asset-light business model will continue to be a strength for our cash generation going forward. In the second quarter, we have further built on our platform to reach Eltel’s targets for profitable growth in a mid- to long-term perspective. Acquisitions completed in the second quarter – Celer in Finland and U-Serv and EVB in Germany – are all examples of acquisitions that expand our local presence and add scalability of the business. In addition, we still have a good pipe-line of future potential acquisitions. Our organic growth continues to be supported by the visible positive long-term drivers in the Infranet market. This applies to all segments and business units, especially within fibre and smart meters. Our strong market position gives us excellent opportunities to benefit from our customers’ increased investment plans that are driven by needs for the end-user and by new regulations. During the quarter, I decided, after twelve years at Eltel, to leave my position as CEO. With the set strategy and a strong and competent management team in place, I am certain that Eltel will continue to be the forerunner in transforming the Infranet industry. The recruitment process is on-going and I will remain fully focused in my position until a successor is in place. –Axel Hjärne, President and CEO For further information:Ingela UlfvesVP – Investor Relations and Group CommunicationsTel: +358 40 311 3009,  This information is information that Eltel AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CET on 19 August 2016. About EltelEltel is a leading European provider of technical services for critical infrastructure networks – Infranets – in the segments of Power, Communication and Transport & Security, with operations throughout the Nordic and Baltic regions, Poland, Germany, the United Kingdom and Africa. Eltel provides a broad and integrated range of services, spanning from maintenance and upgrade services to project deliveries. Eltel has a diverse contract portfolio and a loyal and growing customer base of large network owners. In 2015 Eltel net sales amounted to EUR 1,255 million. The current number of employees is approximately 9,600. Since February 2015, Eltel AB is listed on Nasdaq Stockholm.

Infant Bacterial Therapeutics AB (publ), (IBT) Interim report January 1 – June 30 2016

Message from the CEO “In June we announced that the first premature infant had been enrolled and dosed in the Company´s Phase ll clinical trial. This Phase ll trial is a randomized, double blind, parallel group, dose escalation, placebo-controlled multicenter study to investigate the safety and tolerability of IBP-9414 administered in preterm infants. The multicenter trial is being conducted in a number of neonatal intensive care units in the US and will enroll 120 premature infants in total. The first planned independent Data Safety Monitoring Board (DSMB) evaluation of safety data was performed on August 12th. The DSMB concluded that there were no objections to dose escalation based on the information provided to the DSMB. We are very pleased that the trial has begun and is progressing according to plan. This is another major milestone in the development of a new pharmaceutical for this very sensitive group of patients.” Staffan Strömberg, Chief Executive Officer Financial summary  SEK 000’s 2016 2015 Jan-Jun Jan-Jun Net sales - -Net profit/loss -16 078    -9 673   Result after tax -16 284    -9 680   Total assets  133 127     15 917   Cash flow for the period  71 973     463   Cash  116 384     1 517   Earnings per share, weighted -6,4 -5,4average, before and after dilution(SEK)Equity per share (SEK) 23,1 207,0Equity ratio (%) 95% 65% Significant events during the first six months · The Annual General Meeting decided on 8 February on repayment of conditional shareholder contributions by offsetting previously received group contributions by SEK 20.6m · BioGaia AB (publ) distributed its entire holding (94.5 % of shares and 96 % of votes) in IBT to BioGaia’s shareholders · IBT’s shares were listed on Nasdaq First North · IBT completed a guaranteed share issue which generated approximately SEK 89m after deduction of issue costs · The first premature infant has been enrolled and dosed in the Company’s Phase ll clinical trial Significant events after the reporting period · There were no significant events after the reporting period prior to the date of publication of this interim report For additional information please contact Staffan Strömberg, CEO, phone: +46 8 410 145 55 Peter Rothschild, Chairman of the Board, phone: +46 8 410 145 55 Infant Bacterial Therapeutics AB Bryggargatan 10 111 21 Stockholm Phone: +46 8 410 145 55  Publication The information in this Interim Report is such which IBT is obliged to make public pursuant to the EU Market Abuse Regulation and which is to be made public according to the Nasdaq regulations for companies listed on Nasdaq First North. The information was submitted for publication, by the CEO stated above, at 08.00 a.m. CET on 19 August, 2016.

Interim Report

The second quarter in figures · Total net sales amounted to TSEK 1,855 (918). · The loss after tax amounted to TSEK 14,468 (10,939). · The loss per share amounted to SEK 1.75 (1.80). · The cash flow from current operations was negative in the amount of TSEK 13,112 (13,858). · Significant margin improvement with gross margin increasing to 30.1% in Q2 (-34.5% Q2 15).  The first half-year in figures · Total net sales amounted to TSEK 2,921 (1,975). · The loss after tax amounted to TSEK 26,068 (20,118). · The loss per share amounted to SEK 3.15 (3.63). · The cash flow from current operations was negative in the amount of TSEK 24,359 (23,055). · Significant margin improvement with gross margin increasing to 28.7% (-14.6%).  Important events during the quarter · Record growth in key market Germany with total sales up 124% and electrode sales volume up 212%. · SciBase will insource the strategically important production of the disposable electrode from Ginolis. The companies have mutually agreed to transfer the manufacturing to SciBase when Ginolis AB has completed the next milestone in the stepwise automation of the production process.  · As part of the Nevisense PMA-process, a series of inspections were carried out by the US FDA with good results.  · The AGM was held on May 16, 2016. · SciBase participated in the Euromelanoma week May 9-13, a European initiative to highlight skin-cancer.   · On April 25th, the Annual Report for 2015 was published. Important events after the end of the period A milestone was passed when the hundredth clinic in Germany installed a Nevisense device. Financial overview  +---------------------------+-----+------+-----+------+------------+------------+| | | | | |Jul 1 2015 -| |+---------------------------+-----+------+-----+------+------------+------------+| |Apr 1 |Jan 1 |Jun 30 2016 |Jan 1-Dec 31|| |- June |- June | | || |30 |30 | | |+---------------------------+-----+------+-----+------+------------+------------+|THE GROUP |2016 |2015 |2016 |2015 |Rolling-12 |2015 |+---------------------------+-----+------+-----+------+------------+------------+|Net sales, SEK ths |1 855|918 |2 921|1 975 |5 097 |4 151 |+---------------------------+-----+------+-----+------+------------+------------+|Gross margin, % |30,1%|-34,5%|28,7%|-14,6%|24,1% |2,5% || | | | | | | |+---------------------------+-----+------+-----+------+------------+------------+|Equity/Asset ratio, % |92,7%|91,4% |92,7%|91,4% |92,7% |95,1% |+---------------------------+-----+------+-----+------+------------+------------+|Net indebtness, multiple |0,08 |0,09 |0,08 |0,09 |0,08 |0,05 |+---------------------------+-----+------+-----+------+------------+------------+|Cash equivalents, SEK ths |108 |165 |108 |165 |108 786 |133 736 || |786 |595 |786 |595 | | |+---------------------------+-----+------+-----+------+------------+------------+|Cashflow from operating |-13 |-13 |-24 |-23 |-47 892 |-46 588 ||activities, SEK ths |112 |858 |359 |055 | | |+---------------------------+-----+------+-----+------+------------+------------+|Earnings per share (before |-1,75|-1,80 |-3,15|-3,63 |-5,73 |-6,01 ||and after dilution), SEK* | | | | | | |+---------------------------+-----+------+-----+------+------------+------------+|Shareholder's equity per |14,45|27,41 |14,45|30,13 |14,45 |21,09 ||share, SEK* | | | | | | |+---------------------------+-----+------+-----+------+------------+------------+|Average number of shares, |8 285|6 085 |8 285|5 535 |8 285 |6 910 ||000'* | | | | | | |+---------------------------+-----+------+-----+------+------------+------------+|Number of shares at closing|8 285|8 285 |8 285|8 285 |8 285 |8 285 ||of period, 000'* | | | | | | |+---------------------------+-----+------+-----+------+------------+------------+|Share price at end of |17,20|43,00 |17,20|43,00 |17,20 |31,00 ||period, SEK | | | | | | |+---------------------------+-----+------+-----+------+------------+------------+|Average number of employees|19 |13 |19 |14 |15 |14 |+---------------------------+-----+------+-----+------+------------+------------+|*Adjusted for in May 2015 | | | | | | ||performed reversed split, | | | | | | ||40:1 | | | | | | |+---------------------------+-----+------+-----+------+------------+------------+

EBITDA growth of 23.3 percent and improved margins

January – June 2016 · Sales amounted to SEK 847.4 million (852.9), a decrease of 0.6 percent before adjustments for acquired and divested businesses. Adjusted for the acquisition of Drew Tech and the divestment of Opus Equipment the revenue growth amounted to 6.7 percent. · Operating profit before depreciation (EBITDA) amounted to SEK 177.5 million (145.1), corresponding to an EBITDA margin of 20.9 percent (17.0), and an EBITDA growth of 23.3%.  · Cash flow from operating activities amounted to SEK 103.8 million (96.0). · Net financial income/expense include foreign exchange differences of SEK 9.9 million (16.3). · Profit for the period amounted to SEK 52.6 million (40.1).  · Earnings per share after dilution amounted to SEK 0.18 (0.15). April – June 2016 · Sales amounted to SEK 452.3 million (452.1), which equals the turnover for the same period previous year before adjustments for acquired and divested businesses. Adjusted for the divestment of Opus Equipment the revenue growth amounted to 8.9 percent. · Operating profit before depreciation (EBITDA) amounted to SEK 116.1 million (94.2), corresponding to an EBITDA margin of 25.7 percent (20.8).  · Cash flow from operating activities amounted to SEK 94.8 million (65.4). · Net financial income/expense include foreign exchange differences of SEK 17.9 million (-37.9). · Profit for the period amounted to SEK 50.5 million (-1.5).  · Earnings per share after dilution amounted to SEK 0.17 (-0.01). Notable events during the second quarter · Opus Group issues 5-year SEK 500 million senior unsecured bond Mölndal, August 19, 2016Opus Group AB

Interim Report Pricer AB January – June 2016

Improved operating margin and profit, weaker order intake   Second quarter 2016     · Net sales of SEK 204.2 M (239.4), a decrease of 15 percent compared to the same period last year · Operating profit of SEK 16.3 M (8.2) and profit for the period of SEK 14.6 M (7.0) · Operating profit includes costs affecting comparability related to restructuring of SEK 6.5 M (0) · Cash flow from operating activities improved to SEK 21.1 M (-57.9) · Order intake of SEK 154 M (296), a decrease of 48 percent compared to the same period last year · The backlog is approximately SEK 163 M (303), whereof the majority is expected to be invoiced in the third and fourth quarter of 2016 · The Board appointed Charles Jackson as acting CEO of Pricer AB as per 16 May 2016 after Jonas Vestin resigned as President and CEO of Pricer AB +--------------------+----------+---------+--------+--------+---------+|Amounts in SEK M | Q 2| Q 2|6 months|6 months|Full year||unless otherwise | | | | | ||stated | | | | | |+--------------------+----------+---------+--------+--------+---------+| |      2016|     2015| 2016| 2015| 2015|+--------------------+----------+---------+--------+--------+---------+|Order intake | 154| 296| 458| 565| 792|+--------------------+----------+---------+--------+--------+---------+|Net sales* | 204,2| 239,4| 359,6| 382,3| 864,8|+--------------------+----------+---------+--------+--------+---------+|Gross margin* | 27,6%| 18,6%| 26,6%| 20,1%| 21,8%|+--------------------+----------+---------+--------+--------+---------+|Operating profit | 16,3| 8,2| 18,5| 9,1| 47,8|+--------------------+----------+---------+--------+--------+---------+|Operating margin | 8,0%| 3,4%| 5,1%| 2,4%| 5,5%|+--------------------+----------+---------+--------+--------+---------+|Cash flow from | 21,1| -57,9| 41,9| -15,9| 101,4||operating activities| | | | | |+--------------------+----------+---------+--------+--------+---------+|Profit for the | 14,6| 7,0| 15,7| 8,3| 37,0||period | | | | | |+--------------------+----------+---------+--------+--------+---------+|Earnings per share | 0,13| 0,06| 0,14| 0,08| 0,34||(SEK) | | | | | |+--------------------+----------+---------+--------+--------+---------+ * See Note 1 in the complete version of the interim report.Comments from acting CEO, Charles JacksonThe second quarter showed sustained high demand from the existing customer base but, due to the postponement of a few major project procurements, order intake was lower than in the previous year and did not meet the company’s own expectations. We can however be pleased of a significant strengthening of the gross margin which, combined with good cost control, raised operating profit compared to last year despite lower sales.  We do not consider that the order intake level during the second quarter reflects a market slowdown but see it rather as due to the investment horizon of individual customers combined with delayed call-offs under previously reported framework agreements. The international grocery business is a structurally and financially sensitive market in which investment decisions sometimes take longer than we would like. As previously reported, major projects in individual quarters affect the consistency of our figures.Existing framework agreements are recognized as order intake only in the quarter in which call-offs take place. The deliveries to our Norwegian partner Strongpoint, relating to the Bunnpris grocery chain, were pushed back in relation to the previously estimated timetable with only a small portion being included in recognized order intake for the first half. The total order value is still estimated at approximately SEK 100 M which means that we expect additional order intake related to Bunnpris during the current year while deliveries and installation will partly be pushed into to 2017. Furthermore, the French grocery chain Système U did not start call-offs under its framework agreement until the end of the second quarter, which was slightly later than expected. Order intake under this framework agreement is now expected to continue according to plan during the second half of 2016 and in 2017.Net sales decreased by 15 percent compared to the same quarter in 2015, from SEK 239 M to SEK 204 M. Pricer delivered several major orders in the second quarter of last year which was not the case this quarter. However, supported by improved product costs and an advantageous product mix, we raised the operating margin in the second quarter of 2016 considerably compared with the previous year, from 3.4 percent to over 11 percent if we exclude the non-recurring costs in the quarter attributable to the change of CEO and other staff changes. Cash flow from operating activities also improved by a full SEK 78.8 M compared with last year as a result of less capital being tied in supply chain and inventory combined with better control of our working capital in relation to the fluctuations we are seeing in net sales and order backlog.To counter these fluctuations, which to some extent are hard to predict, we work continuously to improve our operational processes in order to achieve greater scalability while retaining control of costs. During the past six months we have also achieved a marked improvement of the cost structure which has both strengthened our competitiveness and reduced the need to tie up capital in the production chain. In parallel, we are also investing in more intensive marketing in a number of selected geographies where we want to be in a position to land the major projects. A market that is expected to take off in the coming years is the USA. The USA is the world’s single largest grocery market and trends such as increased automation, active price strategies and increased interactivity with customers can be clearly seen here which strengthens interest in Pricer’s solutions. Several American retail chains within both the grocery trade and the DIY sector have ongoing test installations, a significant step in the sales cycle.Our strategy to expand our offer into digital services that increase store profitability and enhance the shopper experience remains unchanged. Pricer’s aim is to be a key partner as the world’s major retail chains develop their omni-channel concepts. This is expected to include both global platform solutions and local customizations. A local presence and proximity to customers are pre-requisites to be successful. As part of this work we currently have several test installations with strategic customers in France and Sweden, among other countries. Here, Pricer’s platform guides consumers via an interactive digital map of the store which will, we believe, result in enhanced shopper experience and increased sales. This solution for product positioning is in demand in all our geographical markets and here we intend to accelerate development in order to meet demand from several of the major retail chains in strategically important markets such as France and the USA.For further information, please contact:Charles Jackson, acting CEO, or Helena Holmgren, CFO, Pricer AB: +46 8 505 582 00.This information is information that Pricer AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency by the contact persons set out above, at 8:30 CET on August 19, 2016.

Zmarta Group continues to deliver in line with its growth strategy

Zmarta Group (Ceratiidae II AB (publ.) and its subsidiaries) has today published its interim report for the second quarter 2016. The comparative figures (in parentheses) show the second quarter 2015. · Revenue for the quarter amounted to SEK 114.2 million (78.3), an increase of 46% · Adjusted EBITDA for the quarter amounted to SEK 34.9 million (16.5), an increase of 111% · Operating profit for the quarter amounted to SEK 29.5 million (10.1), an increase of 193% · Net income for the quarter amounted to SEK 18.0 million (0.7), an increase of 2 340% · Operating cash flow before tax and other items amounted to SEK 34.9 million (16.6), an increase of 111% For the period from January-June 2016: · Revenue for the first six months amounted to SEK 219.3 million (158.3), an increase of 39% · Adjusted EBITDA for the first six months amounted to SEK 65.1 million (35.6), an increase of 83% · Operating profit for the first six months amounted to SEK 54.3 million (22.6), an increase of 140% · Net income for the first six months amounted to SEK 31.0 million (5.3), an increase of 482% · Operating cash flow before tax and other items amounted to SEK 48.4 million (27.5), an increase of 76%   “We are happy to continue our strong performance during the second quarter as well, with very strong revenue growth across all our markets”, says Björn Lander, CEO of the Zmarta Group. On 6 July 2016, Ceratiidae I AB, the owner of Ceratiidae II AB (publ.), entered into a share purchase agreement with Bauer Media Group relating to the disposal of Zmarta Group. The transaction, which is subject to the fulfillment of certain conditions, is expected to close in September/October this year. The report can be downloaded from

Bulten signs additional contract with major Russian automotive manufacturer

“With this contract, we have made a significant breakthrough in the Russian market and further strengthened our position as manufacturer of high quality fasteners. We see good opportunities to continue to grow the business and increase our market share,” says Tommy Andersson, President and CEO of Bulten. Deliveries are expected to start in the second quarter 2017 to gradually increase up to full capacity in 2018. After that, deliveries will continue over a number of years related to the life span of the vehicle, which is normally between 5 to 10 years, with a gradual slowdown as the contract nears its end. The full annual value is expected to reach EUR 700 thousand in 2018 and then follow the life span of the vehicle and the volume curve. For further information, please contact:Tommy Andersson, President and CEOKamilla Oresvärd, SVP Corporate CommunicationsTel: + 46 (0)70-520 59 17, e-mail: This information is information that Bulten AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the Senior Vice President Corporate Communications set out above, at 08:45 CET on August 19, 2016. Bulten AB (publ) is one of the leading suppliers of fasteners to the international automotive industry. The company’s product range includes everything from customer-specific standard products to customized special fasteners. The company also provides technical development, line-feeding, logistics, material and production expertise. Bulten offers a Full Service Provider concept or parts thereof. The company was founded in 1873, has some 1,200 employees in nine countries and head office in Gothenburg. The share (BULTEN) is listed on Nasdaq Stockholm. Read more at

Dreamjob in the Arctic: Aurora borealis watch

When the blue moment turns into black in Finnish Lapland, an exciting wait begins. Will the arctic lights blaze in the sky tonight? Sometimes they flame in the early hours, sometimes closer to dawn. Not many visitors hang on awake all night long. The Arctic Snowhotel has come up with a solution: Aurora borealis watch. The main task of the watch is to stay awake and observe the sky. If northern lights appear, watcher wakes the visitors. No wonder more than 200 people applied for the post last season. Two of them got their dream job. Now the position is open again. There are no specific qualifications for the post, but the lucky candidate has to meet two requirements. – Most of our clients are foreigners, so a good grasp of English is a must. One should also spot the difference between a cloud and aurora borealis, says Heidi Haavikko from Arctic SnowHotel. Assignment does not come without responsibility, as Aurora borealis are one of the biggest attractions in Lapland.  – Many travel here in order to see the northern lights. Now they can go to bed in peace, knowing that if the lights appear, the watch will wake them up, Haavikko says. Arctic SnowHotel lies in the tiny village of Lehtojärvi, 27 kilometres from the center of Rovaniemi. It was built for the first time in 2008. Since then, it has emerged every winter season. The construction work starts in late October, when the ice blocks are lifted up from the nearby lake. The snow is made by multiple snow machines on the site. The beloved speciality of Arctic SnowHotel are the glass-roofed iglus, where one can marvel the Aurora borealis from the comfort of a warm bed. From December 2016 onwards a trip to Lapland gets even easier, as Norwegian starts direct flights from Gatwick to Rovaniemi.  For more information: Heidi Haavikko(+358) 40 845

Genes responsible for risk of heart attack, stroke, and related cardiometabolic diseases identified

The identified level of complexity and interaction among these genes also includes processes that lead to heart attack and stroke.  “By analyzing gene-expression data from multiple tissues in hundreds of patients with coronary artery disease, we were able to identify disease-causing genes that either were specific to single tissues or acted across multiple tissues in networks to cause cardiometabolic diseases,” said Johan Björkegren, MD, PhD, principal investigator of the study, Professor of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, visiting professor at University of Tartu and senior investigator at the Karolinska Institutet.  The research was done as part of the STARNET study - the first systematic analysis of RNA sequence data from blood, vascular, and metabolic tissues from patients with coronary artery disease (CAD). RNA sequences are copies of the DNA in each cell that serve as templates for protein synthesis and determine whether a tissue remains healthy or becomes diseased.  “Genome-wide association studies (GWAS) have identified thousands of DNA variants increasing risk for common diseases like CAD,” said Dr. Björkegren. “However, while GWAS was an important first line of investigations of the inheritance of CAD, in order to translate these risk markers into opportunities for new diagnostics and therapies, we must now move into a new phase of discovery and identify the genes perturbed by these DNA variants responsible for driving disease development. Unraveling disease-driving genes with their tissue-belonging, as we have started to achieve using STARNET, will also be a prerequisite for developing precision medicine with individualized diagnostics and therapies.”  In collaboration with AstraZeneca and SciLifeLab team, Dr. Björkegren’s team has also used STARNET to try to improve drug target development.   “We are excited about our joint project with Dr. Björkegren’s team at Karolinska Institutet and AstraZeneca, which now with the Science report has delivered the first wave of ground-breaking data that we have supported for the past three years,” said Li-Ming Gan MD, PhD, a co-author of the study, Senior Medical Director and collaboration lead at AstraZeneca. “During the course of our project we have found that Dr. Björkegren’s datasets including STARNET provide essential translation information to help us identify new drug targets, as well as informing on existing targets in cardiovascular and metabolic diseases, a main therapy area for AstraZeneca.”  STARNET was launched in 2007 by Dr. Björkegren, and Arno Ruusalepp MD, PhD, Chief Cardiac Surgeon at Tartu University Hospital in Estonia, and senior co-author on the study. Unlike similar studies, it obtained samples of several key tissues from 600 clinically well-characterized patients with CAD during coronary artery bypass surgery. By using sophisticated data analysis techniques, the researchers found that the gene expression data were highly informative in identifying causal disease genes and their activity in networks for CAD, related cardiometabolic diseases as well as Alzheimer’s disease.  “One unexpected and thus potentially important finding of the study was that besides the liver, abdominal fat emerged as a key site for regulation of blood lipid levels” said Dr. Franzén, first author and computational biologist in Dr. Björkegren’s laboratory. “For example, a gene called PCSK9, which is implicated in controlling plasma levels of low-density lipoprotein (LDL) - the so-called bad cholesterol - was found to do so by acting in abdominal fat, not in the liver where blood levels of LDL are mainly regulated”.  The gene PCSK9 has lately gained substantial attention as the latest target for lipid-lowering drugs now reaching the market. The STARNET study was supported by the University of Tartu; the Estonian Research Council; Karolinska Institutet - AstraZeneca Joint Research Program in Translational Science; Clinical Gene Networks AB (an SME of the EU-funded integrated project CVgenes@target); the Leducq transatlantic networks; CAD Genomics and Sphingonet; Torsten and Ragnar Söderberg Foundation; Knut and Alice Wallenberg Foundation; the American Heart Association; the National Institutes of Health and the Veterans Affairs.   The DNA genotyping and RNA sequencing were in part performed by the SNP&SEQ technology platform at SciLifeLab National Genomics Infrastructure in Uppsala and Stockholm supported by Swedish Research Council, Knut and Alice Wallenberg Foundation and UPPMAX.  Björkegren is the founder and chairman of the company Clinical Gene Networks AB, CGN. CGN has financially contributed to the STARNET study. Schadt and Ruusalepp are members of CGN board of directors. Björkegren, Michoel and Ruusalepp own equity in CGN and receive financial compensation from CGN. Publication:'Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases'Oscar Franzén, Raili Ermel, Ariella Cohain, Nicholas K. Akers, Antonio Di Narzo, Husain A. Talukdar, Hassan Foroughi-Asl, Claudia Giambartolomei, John F. Fullard, Katyayani Sukhavasi, Sulev Köks, Li-Ming Gan, Chiara Giannarelli, Jason C. Kovacic, Christer Betsholtz, Bojan Losic, Tom Michoel, Ke Hao, Panos Roussos, Josefin Skogsberg, Arno Ruusalepp, Eric E. Schadt, Johan L. M. Björkegren.Science, published online 18th August 2016, doi: 10.1126/science.aad6970

GomSpace (provider of nanosatellites) has entered into a non-binding letter of intent to acquire all shares in NanoSpace AB

Press release Stockholm August 19, 2016       GomSpace (provider of nanosatellites) has entered into a non-binding letter of intent to acquire all shares in NanoSpace AB GS Sweden AB (publ) (the ”Company” or “GomSpace”), parent company of GomSpace ApS, has entered into a letter of intent (“LoI”) with the Swedish company “Svenska rymdaktiebolaget” (the Swedish Space Corporation) regarding the potential acquisition of 100% of the shares in the Swedish company NanoSpace AB. The LOI contains broad terms of a potential transaction with the right for GomSpace to conduct a due diligence investigation and the acquisition is conditional upon both parties entering into a definite agreement containing specific signing and closing terms and conditions yet to be negotiated.     Should the acquisition be completed, the parties have agreed that the purchase price is to be paid with 600,000 new issued shares in GS Sweden AB and with a cash payment of 3,000,000 SEK. Such new issue of shares will be possible for the board of directors to decide upon with support from an authorization granted at an extraordinary general meeting held on April 28, 2016. The potential dilution for the current shareholders will approximately be 2.75%. NanoSpace is a company that develops and provides propulsion technology and products for nanosatellites, and participates in space technology projects funded by the European Space Agency (“ESA”) and Swedish national funding programs.  NanoSpace’s propulsion technology and products are based on the company’s leading expertise in applying MEMS (Micro Electro Mechanical Systems) technology to space propulsion – providing unique advantages in miniaturization and precise thrust control. GomSpace’s wish to acquire NanoSpace AB for the purpose of building up more Swedish activities and to have satellite propulsion products in its portfolio alongside the activities already in Gomspace ApS. Future operational nanosatellite missions will depend on constellations of satellites and therefore require the ability to fly these satellite in an accurate formation - as can be achieved using ability provided by the propulsion technology and products developed by NanoSpace. GomSpace and NanoSpace already collaborate closely in multiple customer projects on integrating NanoSpace propulsion technology into GomSpace satellite platforms. Should the acquisition be completed, Swedish Space Corporation has accepted to make an executive director available for the board of directors in GomSpace. Swedish Space Corporation is a global provider of advanced space services, who enables governmental agencies, companies and other commercial or research institutes to help Earth benefit from space. For more information, please contact:                     Niels Buus (CEO)Tel: +45 40 31 55 57                        Email:  Miscellaneous    +-----------------------------------------------------------------------------+|This information is information that GomSpace is obliged to make public ||pursuant to the EU Market Abuse Regulation. The information was submitted for||publication, through the agency of the contact person set out above, at [•] ||CET on August 19, 2016.   |+-----------------------------------------------------------------------------+ About GS Sweden AB The Company’s business operations are conducted through the wholly-owned Danish subsidiary, GomSpace ApS, with operational office in Aalborg, Denmark. GomSpace is a space company with a mission to be engaged in the global market for space systems and services by introducing new products, i.e. components, platforms and systems based on innovation within professional nanosatellites. The Company is listed on the Nasdaq First North Premier exchange under the ticker GOMX. FNCA Sweden AB is the Company’s Certified Adviser. For more information, please visit our website on  IMPORTANT INFORMATIONThis press release shall not constitute an offer to sell or the solicitation of an offer to acquire any securities, nor shall there be any sale of any securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. Except for the historical information contained herein, this press release contains forward-looking statements. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made, and the facts and assumptions underlying the forward-looking statements may change. Except as required by law, GomSpace disclaims any obligation to update these forward-looking statements to reflect future information, events or circumstances.

Planning for the renovation of the Suomenlinna tunnel begins

Today, the Governing Body of Suomenlinna signed a contract with YIT and Pöyry on renovating the tunnel of the World Heritage Site Suomenlinna. Together with the Governing Body of Suomenlinna, YIT and Pöyry will form an alliance which will be responsible for planning and implementing the project. The budget for the project is EUR 7 million. The project is to be carried out employing the alliance model, which means that the client, users, designers and contractors are involved from the very beginning. The parties to the project will be mutually responsible for the planning, construction and implementation, sharing the risks and benefits related to the project. "It is challenging to implement this project with the alliance model, especially due to its small scale. So far, the model has been primarily applied to large and complex projects, but with Suomenlinna, we get to test what we have learned in a project of an entirely different size. In addition, the unique environment also poses challenges for the implementation of the project. We are very grateful for this opportunity of both implementing the Suomenlinna tunnel project and developing our project models," says Ari Bergström, Vice President of rock construction at YIT. The currently starting development stage of the project is estimated to last until the end of 2016. The development stage will cover the planning of implementation details and exceptional arrangements required by the project. The renovation of the tunnel will begin in the spring of 2017. The sea fortress Suomenlinna is connected to the municipal engineering of the city via a tunnel running under the sea. The residents of Suomenlinna receive their district heating, plumbing, water, electricity and data communication connections through the tunnel. The tunnel is also intended for the use of emergency vehicles. Suomenlinna is a district of Helsinki with about 800 year-round residents, 400–500 workers, depending on the season, and more than 930,000 visitors of the World Heritage Site per year. The tunnel renovation will ensure their continued access to municipal engineering services. For further information, please contact: Hanna Malmivaara, Vice President, Communications, YIT Corporation, tel. +358 (0)40 561 6568,  Ari Bergström, Vice President, YIT Construction Ltd, tel. +358 (0)40 830 7336, YIT creates sustainable cities and better living environment by developing and constructing housing, business premises, infrastructure and entire areas. We focus on providing a first-class customer experience, high quality and continuous development of our diverse expertise. Our operating area covers Finland, Russia, the Baltic countries, the Czech Republic, Slovakia and Poland. In 2015, our revenue amounted to nearly EUR 1.7 billion, and we employ about 5,300 employees. Our share is listed on Nasdaq Helsinki.  

Textron Systems Delivers First TAPV to the Canadian Army

NEW ORLEANS, LA – AUGUST 19, 2016 – Textron Systems Canada Inc., a Textron Inc. (NYSE: TXT) company, announced today the delivery of the first Tactical Armoured Patrol Vehicle (TAPV) ( to the Canadian Army. The Canadian Army is fielding the first vehicles to the 5th Canadian Division Support Base Gagetown and the 2nd Canadian Division Support Base Valcartier.  The TAPV is a 4x4 wheeled armoured vehicle specifically engineered and designed to provide survivability, mobility and versatility over the full spectrum of operations. The comprehensive, modern design is aimed at shielding troops from ballistics and roadside blasts while providing large power reserves for future electronics enhancements, with an ergonomically designed interior for optimum comfort and payload. “We believe the TAPV is the most mobile, survivable and reliable armoured vehicle in the world today,” said Textron Systems Vice President of Land Systems Richard Valenti. “We are excited to start these deliveries to the Canadian Army and support the program through operational capability and beyond.” In April 2016, the TAPV completed a very rigorous Reliability, Availability, Maintainability and Durability (RAMD) test program ( during which it faced multiple operational tests, including driving more than 130,000 kilometers on challenging terrain representing operational profiles prescribed by the Canadian Army. The TAPV’s RAMD testing also included firing the remote weapons station and conducting more than 4,700 hours of remote weapons station usage, including 1,650 hours of silent watch operations. Testing was conducted over three months, day and night, six days per week. The final results showed that the TAPV exceeded the reliability and maintainability requirements of the contract. Textron Systems plans to deliver at least 30 vehicles per month to the Canadian Army with all 500 vehicles scheduled to be delivered by December 2017. The fleet will be distributed across seven bases. The Canadian Army expects to declare full operational capability by mid-2020.

Additional two centers started screening of Multiple Myeloma patients in OV’s APO010 Study

“The opening and inclusion of patients for the screening of MM patients for the APO010 protocol forms the basis of inclusion of patients who are expected to have a high likelihood of responding to APO010.  This DRP™ enables us to develop drugs in a highly focused way where the potential benefit for the patients goes hand in hand with saving time and resources,“ says Adjunct Professor Peter Buhl Jensen, M.D., CEO of Oncology Venture. ”This new immuno-oncology product mimics our immune system, and is a first-in-class product which we believe can become a new treatment option against Multiple Myeloma, “ Peter Buhl Jensen, further comments. APO010 is a FAS-ligand drug that only works when the FAS-receptor is present. To increase response odds, OV uses DRP™ to find patients whose tumor gene signature matches APO010, and therefore high likelihood responders.  OV will screen the patients and include only those with the highest likelihood of response in a phase 2, proof-of-concept clinical trial. About APO010 APO010 is a multimeric form of FAS-ligand for immuno-cancer therapy with a unique mechanism of action. APO010 acts through the FAS-receptor leading to apoptosis of the malignant cells. APO010 is expected to act in synergy with other cancer immunology agents such as ipilimumab and PD-1/PD-L1 inhibitors. The drug candidate is complemented by a companion diagnostic technology (APO010 DRP™) for enrichment of the patient population. APO010 was tested in 25 patients with solid tumors in a phase 1 study. The drug was well tolerated. Pre-clinical studies have revealed that APO010 is highly efficient in Multiple Myeloma. Therefore, a phase 2 trial will be conducted in patients with Multiple Myeloma that have been pre-screened for sensitivity using the APO010 DRP™ technology. There is a great need for effective treatment against Multiple Myeloma, where it is believed that a drug like APO010 can position itself right after Daratumumab which was recently approved for the indication. The market value was over 7 billion USD during 2014. Researchers estimate the value of the cancer immunotherapy market to 35 billion USD by 2023 (Citi GPS). About Multiple Myeloma Multiple Myeloma (bone marrow cancer) is a systemic malignancy in the blood, affecting plasma cells. The introduction of high-dose therapy with autologous stem cell support, and introduction of new therapies like the proteasome inhibitor bortezomib and IMIDs (thalidomide and lenalidomide) has improved the outcome. In spite of this, eventually all patients will experience progressive disease and continue into second and later lines of treatment. OV will approach this important clinical issue by introducing a novel systemic chemotherapeutic treatment together with a predictive biomarker test. Based on DRP™, APO010 will be developed for use in treatment of Multiple Myeloma. About the Drug Response Predictor (DRP™) screening tool This method builds on the comparison between sensitive and resistant human cancer cell lines, including genomic information from cell lines combined with clinical tumor biology and clinical correlates in a systems biology network. For further information, please contact Peter Buhl Jensen, CEO                                                                          Ulla Hald Buhl Telephone: +45 21 60 89 22                                                                  Telephone: +45 21 70 10 49 E-mail:                                                      E-mail: This information is information that Oncology Venture Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on august 19 2016. About Oncology Venture Sweden AB Oncology Venture Sweden AB is engaged in the research and development of anti-cancer drugs via its wholly owned Danish subsidiary Oncology Venture ApS. Oncology Venture has a license to use Drug Response Prediction – DRP™ – in order to significantly increase the probability of success in clinical trials. DRP™ has proven its ability to provide a statistically significant prediction of clinical outcomes from drug treatment in cancer patients in 29 of the 37 clinical studies that were examined. The Company uses a model that alters the odds in comparison with traditional pharmaceutical development. Instead of treating all patients with a particular type of cancer, patients’ tumors genes are screened first and only those who are most likely to respond to the treatment will be treated. Via a more well-defined patient group, the risk and costs are reduced while the development process becomes more efficient. The current product portfolio: LiPlaCis for Breast Cancer, Irofulven developed from a fungus for prostate cancer and APO010 – an immuno-oncology product for Multiple Myeloma.

Saab Receives Order From New Zealand For Tactical Engagement Simulation System

The laser-based TESS capability will be delivered by Saab New Zealand, drawing on over 35 years of tactical engagement simulation design, delivery and support expertise. Saab has a demonstrated track record of delivering on time and on budget, to the American, British, Canadian and Australian (ABCA) armies and to North Atlantic Treaty Organisation (NATO) land forces. Saab’s live training system has been developed and continuously modernised with experience from more than 20 customer nations. “We look forward to working closely with the New Zealand Army to enhance its training outcomes. We are proud to deliver this significant training system to the New Zealand Army, which will now lead the region in the employment of advanced laser-based tactical engagement systems to support training,” says Saab Australasia Head of Training and Simulation, Inger Lawes. “With this agreement and order for training systems, the New Zealand Army will have a market-leading live training system that will improve their training capability. We deliver a modern system that enables a wide range of training scenarios and the highest realism. This order further strengthens our market position within this field”, says Åsa Thegström, head of business unit Training & Simulation within business area Dynamics. Saab will work with the New Zealand Army to deliver a value for money, off-the-shelf TESS capability that will significantly enhance the Army’s ability to conduct and analyse the outcomes of force-on-force exercises. The capability meets the New Zealand Army’s current requirements while providing a platform and capacity for long-term system growth. For further information, please contact: Saab Press Centre, +46 (0)734 180 018, David LedgerMarketing Communications Manager (Australia & New Zealand) +61 (0)421 054 698,  Follow us on twitter: @saab  Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 


· Acquisition of VODRUM Ltd is further proof of The Marketing Group plc’s commitment to ground-breaking expansion plans. · Subsidiary companies, The Brand Theatre, ChannelZero, Ranieri and Slingshot Sponsorship bolster The Marketing Group’s collective expertise and credentials across key geographies and digital marketing specialisms. · Earnings per share jump 9.75% as EBITDA breaks through the 11 million Euro mark. · EBITDA will increase by approximately 16.2% in exchange for a share capital increase of approximately 6.09%. Stockholm, August 22nd, 2016 - THE MARKETING GROUP PLC, a 360 digital company, today announces the strategic acquisition of Vodrum Ltd and its subsidiary businesses in a move designed to further bolster the overall expertise of the group in key markets. Vodrum subsidiary companies include: The Brand Theatre is a Singapore based, global brand consultancy that offers end-to-end branding solutions for various organisations from B2B, B2C, and government that range in size from niche to multinational companies. It brings a wealth of brand experience and global clients to the group. Channel Zero is a creative brand agency that provides high-level strategic thinking and creativity to global brands. Based in Sydney, Channel Zero is the only marketing business in Australia that directly connects brands to grocery buyers with an end-to-end solution that includes packaging and positioning and sales and supply chain management alongside core creative brand strategy. Ranieri is a PR and social media agency with a focus on consumer technology. As a specialist in this sector, Ranieri offers global communications solutions to blue chip and start up brands. Slingshot Sponsorship is a new style of strategic branding agency that delivers partnership platforms to attract global brands. Headquartered in London, and with offices in Singapore, Brazil and Oslo, the business has a portfolio of clients that range from grass roots charities, to leading FTSE 100 companies to global music artists. Joining The Marketing Group plc will give Vodrum subsidiary businesses access to global reach and the full suite of digital marketing capabilities including some of the best talent in the businesses. Jeremy Harbour, Executive Chairman, The Marketing Group plc comments, “There is a huge opportunity for The Marketing Group to make an impact in the space between brands and niche, specialist marketing agencies. Vodrum brings another suite of unparalleled talent to The Marketing Group as we continue to forge ahead with our ambitious acquisition plans.” The deal to acquire Vodrum Ltd and its subsidiaries was agreed at a strike price of EUR 7.65 per share (based on a 10 day volume weighted average price), with a total value of 13,700,000 Euros. Following this acquisition, the total number of Ordinary shares issued by The Marketing Group will increase from 29,420,307 to 31,211,157. This requires the creation of 1,790,850 new ordinary shares, over 89% of which will be subject to a 360-day lockup period. Financials * +-------------------------------------------------+------------+|EBITDA (The Marketing Group) for Year ending 2016|€9,521,885  |+-------------------------------------------------+------------+|EBITDA (Vodrum) for Year ending 2016 |€1,542,499  |+-------------------------------------------------+------------+|Post-acquisition EBITDA |€11,064,384 |+-------------------------------------------------+------------+|Earnings Per Share (Current) |32.3 cents  |+-------------------------------------------------+------------+|Earnings Per Share (Post-acquisition) |35.45 cents |+-------------------------------------------------+------------+|% EBITDA Increase  |16.2% |+-------------------------------------------------+------------+|% Share cap increase  |6.09% |+-------------------------------------------------+------------+|% EPS Increase  |9.75% |+-------------------------------------------------+------------+ *Based on forecast VODRUM Ltd Group Headline Financials                                                            2015                               2016E +------------------------+------------+-------------+-------------+------------+|Company |         T/O|       EBITDA|          T/O|      EBITDA|+------------------------+------------+-------------+-------------+------------+|The Brand Theatre |€769,316 |€385,788 |€1,148,044 |€609,071 |+------------------------+------------+-------------+-------------+------------+|Channel Zero |€2,714,367 |€177,767 |€3,808,657 |€402,059 |+------------------------+------------+-------------+-------------+------------+|Ranieri Public Relations|€1,056,946 |€147,943 |€1,184,009 |€208,672 |+------------------------+------------+-------------+-------------+------------+|Slingshot Sponsorship |€472,271 |€71,595 |€776,895 |€322,697 |+------------------------+------------+-------------+-------------+------------+|TOTAL |€5,012,900 |€783,094 |€6,917,606 |€1,542,499 |+------------------------+------------+-------------+-------------+------------+ RELATED PARTY TRANSACTION This acquisition is classified as a related party transaction as commercial entities in which Unity Group and it’s connected partner companies have an interest in who have provided financial support and services to Vodrum Ltd. As a result, entities that Chairman, Jeremy Harbour is connected with will receive a total of 349,951 shares as part of this transaction and a commercial entity that Director Callum Laing discharges managerial responsibility for will receive 260,085 shares. These shares are 100% locked up. Due to this conflict of interest, both Jeremy and Callum abstained from the vote to acquire Vodrum Limited. There are no materially declarable new clients, shareholders or suppliers as a result of the transaction. On 26 July 2016, The Marketing Group’s creative content agency Nice&Polite announced the tactical acquisition of Digital Virtue and VOQS Limited with a total of 52,771 new ordinary shares. As the forex exchange rate was not taken into account, an additional 8,306 number of shares at a strike price of 4.15 Euros per share will be created to make up for it. This brings the new number of total shares in The Marketing Group post Vodrum acquisition to 31,219,463. VODRUM GROUP COMPANIES The Brand Theatre. Singapore. The Brand Theatre Worldwide group is a brand consultancy. The Brand Theatre offers end-to-end, branding solutions, for various organisations, from B2C, B2B, government, with size ranging from SME to global and multinational companies.  Clients include: EOP21, Leacov, Unipro, CIAP Architecture, Beirut Grill, Face Bistro, Adventus, Credit Xtra, BOCA Asia and JBS Audit (FKA Shanker Ayer). ChannelZero. Sydney. Is a full service creative agency that offers creative strategy and solutions to global brands.  Their sales focused approach is designed to deliver results and differentiate from other companies in the market. Clients include: RFGA Management Pty Ltd, CONAIR, Nestle Australia, Sanitarium, News Local, Ivy College, Adrenaline and Sanity. Ranieri.  London.  A PR and social media agency that specialises in consumer technology and delivers tailored campaigns. Ranieri works with companies from across the UK, as well as around the globe. In addition, the company’s international network of PR partners enables Ranieri to provide fully integrated campaigns in a number of countries.  Clients include: Yubl, Provocraft, Strax, Harmon Kardon, Gibson, Venturer, Seek Thermal, Libratone, Viewquest and Misfit. Slingshot Sponsorship. London. Singapore. Brazil. Oslo. Slingshot Sponsorship helps some of the worlds most forward thinking organisations create sustainable sponsorship platforms that attract global brands. Slingshot Sponsorship is not industry specific, enabling individual to tap into best practice across all sectors including media, events, festivals, sports and charities. Clients include:  Bloodhound, GB TK, NHS, Outlook, Silverpop, Snozone, Terracotta, Wales Rally GB, What Car and Umusic. For more information, please contact Hannah Middleton, Director and Communications DirectorPhone: +65 8193 7625E-mail: Jeremy Harbour, Executive ChairmanPhone: +65 8661 1776E-mail: The Marketing Group in brief The Marketing Group plc was incorporated in May 2015 with the purpose of gathering successful marketing businesses under one roof. The Company comprises a series of independent marketing teams, each with specific expertise and innovative services. The consolidated group supports the subsidiaries with management and coordinating activities as well as a common operating platform. For more information, please visit the Company’s website The Company’s share is listed on Nasdaq First North Stockholm from 8 June 2016 and Mangold Fondkommission AB, +46 8-5030 15 50, is the Company’s Certified Adviser and liquidity provider. ENDS

Notice to extra general meeting in Bonava AB (publ)

Participation To be entitled to participate at the general meeting, shareholder must: · be listed in the shareholders’ register maintained by Euroclear Sweden AB on Tuesday, · give notice of his/her/its intention to attend the general meeting no later than on Tuesday, 20 September 2016, and, where appropriate, inform about the number of advisors who will accompany the shareholder. Shareholder whose shares are registered in the name of a trustee with a bank or a stockbroker must, in order to be entitled to participate at the general meeting, register such shares temporarily in the shareholder’s own name with Euroclear Sweden AB. Such registration must be completed no later than Tuesday, 20 September 2016, and should be requested with the trustee well in advance to this date. Notice of intention to attend the general meeting can be made in writing by mail to the following address: Bonava AB, c/o Euroclear Sweden AB, P.O. Box 191, 101 23 Stockholm, Sweden, or by telephone +46 8 402 92 26. Shareholders that are physical persons are also able to give notice at the company's website Name, personal identification number or corporate registration number, address, telephone number and registered shareholding as well as information about attorney and advisors (maximum two), if any, should be stated when notice is made. If participation is to be based on a power of attorney, such document must be evidenced in writing and be dated. If the power of attorney is issued by a legal entity, a certified copy of a certificate of registration or corresponding document for the legal entity shall be appended. If participation is to be based on a power of attorney, such a document and, when applicable, certificate of registration, should be submitted in connection with the notice of intention to attend the general meeting. Power of attorney forms are available on Bonava's website and will be sent free of charge to those shareholders who so request and notify their postal address. Proposed agenda 1. Opening of the meeting.  2. Election of chairman of the meeting. 3. Drawing up and approval of voting list. 4. Approval of the agenda. 5. Election of two persons to verify the minutes, in addition to the chairman. 6. Determination of whether the meeting has been duly convened. 7. Resolution regarding:A. A long-term performance-based incentive plan.B. Authorisation for the board of directors to resolve on execution of acquisition of shares of series B in Bonava and resolution to transfer shares of series B in Bonava.    Proposals Item 7:The board of directors proposes that the extra general meeting resolves on a long-term performance-based incentive plan (LTIP 2016) for Bonava AB (publ) ("Bonava") and authorisation for the board of directors to resolve on execution of acquisition of shares of series B in Bonava as well as the general meeting resolves on transfer of shares of series B in Bonava according to items A. and B. below. A. Long-term performance-based incentive plan Participants in LTIP 2016 LTIP 2016 comprises approximately 25 employees consisting of members of the senior management and certain key personnel within the Bonava group, divided into three categories. The first category comprises Bonava’s managing director (CEO), the second category comprises the CFO and the BU-managers and the third category comprises the rest of the senior management and other persons who have been considered to have a direct or indirect impact on the results of Bonava. New personnel that have been recruited but not yet commenced their employment with the Bonava group when the notification of participation in the plan has to take place, can be offered participation on the condition that their employment starts (wherefore the number of participants in the different categories might be adjusted). The personal investment, number of share rights and vesting period To participate in the LTIP 2016, the participant must invest in a personal shareholding in Bonava ("Investment Shares"), which shall be allocated to the LTIP 2016. The Investment Shares shall be acquired specifically for the LTIP 2016. The participant can choose to invest a maximum of two months' salaries (according to level of monthly salary in August 2016) before taxes in the LTIP 2016.[1] The investment can be made at any of the following investment levels: 25, 50, 75 or 100 per cent of the maximum investment. For the CEO, each Investment Share entitles to six (6) share rights, for the second category of participants, each Investment Share entitles to five (5) share rights and for the third category, each Investment Share entitles to four (4) share rights. Allocation of shares of series B in Bonava, if any, shall normally occur within two weeks after the announcement of Bonava's interim report for the third quarter 2019 (the "Vesting Period", which commence when the participant enters into an agreement of participation in the plan). Terms for the share rights For the share rights the following conditions shall apply: · The share rights are allocated free of charge after some time following the general meeting. · The share rights may not be transferred or pledged. · The right to receive shares of series B pursuant to the share rights requires that the participant has not sold any of the Investment Shares and, with some limited exceptions, that the participant remains employed within the Bonava group during the Vesting Period. Allocation also requires that Bonava fulfils the performance targets as described under "Performance targets" below. · In order to align the participants’ interests with those of the shareholders, Bonava will compensate the participants if Bonava’s dividends, viewed over the whole Vesting Period, exceed the level stipulated in the company's dividend policy. Dividend compensation is made in relation to the shares of series B that the participants receive. · The maximum value that a participant can receive in connection with allocation of shares of series B is limited to 400 per cent of the share price (including any compensation that the participants receive for paid dividends). The share price shall be calculated as the average last price paid for Bonava’s share of series B on Nasdaq Stockholm during a period of twenty trading days immediately following the date of the extra general meeting. Performance targets Allocation of shares of series B based on the participant's holding of share rights relates to the level of fulfilment of two performance targets, whereof one relates to Bonava's operating profit (EBIT) and the other relates to Bonava's average return of capital employed (ROCE). The measurement period for measuring to which extent the performance targets are fulfilled runs during the period 1 July 2017 – 30 June 2019 (the "Measurement Period"). A minimum level and a maximum level for each of the performance targets have been established by the board of directors. It is required that the maximum level for both performance targets have been fulfilled, in order for every share right to entitle to one share of series B in Bonava. Where the level of fulfilment is between the minimum and maximum levels, allocation will be made on a linear basis, with 70 per cent weighting on the performance target for Bonava's operating profit (EBIT) and 30 per cent weighting on Bonava's average return on capital employed (ROCE). Allocation of shares of series B requires that the minimum levels for both performance targets are fulfilled. Bonava intends to present the level of fulfilment of the performance targets after the closure of the plan. If the total shareholder return (TSR) on the company’s shares of series B is negative during a measurement period, the allocation of shares of series B shall be reduced by 50 percent. This measurement period runs from and including 26 September 2016 (i.e. the day for the extra general meeting) up to and including the date of the announcement of Bonava's interim report for the third quarter 2019. Scope and hedging The maximum number of shares of series B in Bonava which may be allocated under the LTIP 2016 shall be limited to 338,903 (excluding compensation for dividend, if any) which represents approximately 0.3 per cent of all shares and approximately 0.1 per cent of all votes in the company. The number of shares of series B included in the LTIP 2016 shall, in accordance with the detailed conditions that the board of directors stipulates, be subject to recalculation if Bonava implements a bonus issue, a reversed share split or a share split, a rights issue or similar actions, taking into account customary practice for similar incentive plans. The board of directors has considered two alternative hedging methods for the LTIP 2016; either a hedging arrangement (equity swap) with a bank securing delivery of shares of series B under the plan or transfer of shares of series B in Bonava to entitled participants in the LTIP 2016. The board of directors considers the latter alternative to be the main alternative. The board of directors has therefore proposed that the general meeting shall authorise the board of directors to resolve on execution of acquisition of shares of series B in Bonava as well as resolve on transfer of shares of series B in Bonava that are held by the company in accordance with item B. below. The board of directors also proposes that the board of directors shall have the right to execute transfer of shares of series B in Bonava, which are held by the company, on Nasdaq Stockholm to cover social security costs under the plan. Should the general meeting, however, not approve of the board of directors’ proposal under item B., the board of directors may enter into the hedging arrangement described above with a bank to secure the obligation of the company to deliver shares of series B under the plan. Such a hedging arrangement with a bank may also be used for the purpose to cover social security costs that accrue under the LTIP 2016. Based on a constant share price during the plan’s term, a Vesting Period of three (3) years as well as some additional assumption, the total cost of the LTIP 2016 including social security costs is estimated to amount to approximately MSEK 40, which on an annual basis corresponds to approximately 1.6 per cent of Bonava's total staff costs during the financial year 2015. B. Authorisation for the board of directors to resolve on execution of acquisition of shares of series B in Bonava and resolution to transfer shares of series B in Bonava The board of directors’ proposal to authorise the board of directors to resolve on execution of acquisition of shares of series B in Bonava and resolution to transfer shares of series B in Bonava as set out below, provides that the general meeting first has resolved on a long-term performance-based incentive plan (LTIP 2016) in accordance with item A. above. Acquisition of shares of series B in Bonava The board of directors proposes that the general meeting resolves to authorise the board of directors, for the period until the next annual general meeting, on one or several occasions, to resolve on execution of acquisition of shares of series B in the company in accordance with the following. · A maximum of 411,386 shares of series B may be acquired (or a higher number of shares of series B due to recalculation as a result of a bonus issue, a share split, a rights issue or similar actions). · Acquisition of shares of series B shall be conducted on Nasdaq Stockholm and to a price per share of series B that is within the registered range for the share price prevailing at the time (the so-called spread), i.e. the range between the highest purchase price and the lowest selling price, taking into consideration the, from time to time, applicable rules set out in the Nasdaq Stockholm Rule Book for Issuer. When an acquisition is made by a stock broker on behalf of the company, the price for shares of series B may, however, correspond to the volume weighted average price during the time period within which the shares of series B were acquired, even if the volume weighted average price on the day of delivery to the company falls outside the spread. · Payment for shares of series B shall be made in cash. · Acquisition shall be made for the purpose of securing the company's obligations (including costs for social security costs) under the LTIP 2016 and other, at any time, performance-based incentive plans resolved by a general meeting. Transfer of shares of series B in Bonava to participants in the LTIP 2016 The board of directors proposes that the general meeting resolves to transfer shares of series B in the company in accordance with the following. · Not more than 338,903 shares of series B in Bonava may be transferred (or the higher number of shares of series B due to recalculation as a result of a bonus issue, share split, rights issue or similar actions). · The shares of series B may be transferred to participants in the LTIP 2016 who under the terms for the LTIP 2016 are entitled to receive shares. · Transfer of shares of series B shall be made at the time and according to the other terms pursuant to which participants in the LTIP 2016 are entitled to receive shares of series B. The reason for deviating from the shareholders' preferential rights is that the transfer of shares of series B is part of the execution of the LTIP 2016. Therefore, the board of directors considers the transfer of shares of series B in accordance with the proposal to benefit the company. Transfer of shares of series B in Bonava on Nasdaq Stockholm Further, the board of directors proposes that transfer also may take place of a maximum of 72,483 shares of series B on Nasdaq Stockholm to cover costs related to social security costs under the LTIP 2016. Transfer in accordance with this section shall be made prior to the next annual general meeting on Nasdaq Stockholm within the registered range for the share price for Bonava's share of series B from time to time. The reason for deviating from the shareholders' preferential rights are the same as set out under the heading "Transfer of shares of series B in Bonava to participants in the LTIP 2016" above. Majority requirements A resolution by the general meeting in accordance with item 7. B. above is valid when supported by shareholders representing at least nine tenth of both the votes cast and the shares represented at the general meeting. Shareholder's right to request information The shareholders are hereby reminded of their right to request information from the board of directors and the managing director in accordance with the Swedish Companies Act Ch. 7 § 32 at the general meeting. Shares and votes At the day of this notice the total number of shares in the company amount to 108,435,822 shares, of which 14,522,665 are shares of series A and 93,913,157 are shares of series B. Each share of series A represents ten (10) votes and each share of series B represents one (1) vote. The total number of votes in the company amounts to 239,139,807 votes at the day of this notice. Bonava does not hold any own shares.  Documents The board of directors' complete proposal and other documents that shall be made available under the Swedish Companies Act, will be available to the shareholders at the company's office at Vallgatan 3 in Solna, Sweden, and on the company's website no later than three weeks before the general meeting and will also be distributed to shareholders who have requested it and have stated their postal address. ---------------------------------------------------------------------- Solna in August 2016 Bonava AB (publ) The Board of Directors For more information, please contact: Ann-Sofi Danielsson, CFO and Head of Investor Relationsann-sofi.danielsson@bonava.comTel: +46 706 740 720 Bonava’s media line: +46 700 887 133, E-mail: Bonava is a leading residential development company in Northern Europe. Born out of NCC, Bonava has been creating homes and neighbourhoods since the 1930’s. Today Bonava has 1,400 employees and operates in Sweden, Finland, Denmark, Norway, Germany, St. Petersburg, Estonia and Latvia with sales of SEK 13 billion. Bonava’s shares are listed on Nasdaq Stockholm.For more information about us: ( ---------------------------------------------------------------------- [1] The possibility to invest two months’ salaries in LTIP 2016, and not just one months’ salary, is given as the LTIP 2016 is the first incentive plan for employees in Bonava. Accordingly, there are no former incentive plans that expire during 2017 and 2018.

Nel ASA: Has secured repeat-order for two new hydrogen stations and has initiated production of new generation H2Station®

(Oslo, 22 August 2016) Nel Hydrogen Solutions has secured a repeat-order for two new CAR-200 hydrogen stations from an udisclosed European customer. Nel Hydrogen Fueling, formerly known as H2 Logic A/S and a division of Nel ASA (Nel), has initiated production of CAR-200, the latest generation H2Station®. “We are very pleased to begin production of the new generation H2Station® at our current factory in Herning. Customer feedback for the fueling station has been very positive so far. A repeat-order being secured even before the first unit has been installed with the customer, both confirms that the product is meeting market expectations, but also sets the stage for our growth moving forward,” says Jacob Krosgaard, Senior Vice President of Nel Hydrogen Solutions, a newly established division of Nel. The repeat order for two additional H2Station® CAR-200 and associated equipment has a total value of approx. EUR 2 million and is planned for delivery in 2017. -- ENDS -- For additional information, please contact: Jon André Løkke, CEO, +47 90 74 49 49 Bjørn Simonsen, market development and public relations director, + 47 97 17 98 21 About Nel Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today.

Addnode Group acquires software supplier Stamford and strengthens its position in the retail and real estate industry

Addnode Group acquires IT companies Stamford and Stamford Hero in Karlstad AB with forty employees. The two companies have more than 25 years of software experience for customers with high demands within the retail and real estate industry. The Stamford companies will be merged with Addnode Group’s existing subsidiary, Prosilia. The two merged operations will be conducted under the name Stamford. - Looking at Stamford and Prosilia, there are great synergies between the companies, both on the business and technical side. This acquisition strengthens our customer offering while at the same time opening up for exciting business opportunities, says Andreas Wikholm, President of Addnode Group’s business area Process Management. - We at Stamford have an extremely positive attitude about the merger with Prosilia. Our resources within development integrates perfectly with the system environment of Prosilia. The merger enables Stamford to grow within an organization with greater resources, which is favorable for both our customers and employees, says Lars Järner, founder of Stamford. Andrea Kösa, currently CEO of Prosilia will manage the merged company and Stamford’s former CEO will become Vice President of Sales. Completion takes place on September 1, 2016, and the company will be a part of Addnode Group’s business area Process Management. The acquisition is paid in cash and promissory notes issued to the sellers. The acquisition is expected to have a marginally positive impact on Addnode Group’s earnings per share. 

Japanese publisher Mainichi Shimbun expands their agreement with Cxense

Oslo, Norway – 22 August 2016 – Cxense ASA (OSE: CXENSE) today announced that the Japanese publisher Mainichi Shimbun has expanded its agreement with Cxense to include Cxense Video. Founded in 1872, Mainichi Shimbun operates both local and national newspapers and magazines as well as online and mobile sites. The name carries significant weight: Mainichi Shimbun is the oldest newspaper still in publication in Japan today, the most award-winning paper in Japan, and the only Japanese newspaper to have won a Pulitzer prize. Mainichi will use Cxense Video to steer viewers to their on-demand video assets and increase user engagement. The Japanese publisher already licenses Cxense personalization and advertising solutions through Cxense Insight, Content, DMP and Advertising. Combining these with Cxense Video enables Mainichi to increase dwell time and opportunities to deliver targeted advertising and thereby boost conversion and revenue generation. About Cxense Cxense (pronounced “see-sense”) enables the world’s leading media, e-commerce and consumer brands to take control of their audience data to deliver more engaging and personalized user experiences. Businesses using Cxense’s advanced real-time analytics, data management (DMP), advertising, search and personalization technology gain more engaged users, increased digital revenue and higher sales conversions. Cxense is headquartered in Oslo, Norway, with offices worldwide. Customers include the Wall Street Journal, USA Today (Gannett), Grupo Clarin, El Pais, Bonnier, Naspers, Ebay, The Golf Channel, PGA, NBA, NFL, ABC News, FOX Sports, Singapore Press Holdings, South China Morning Post, AEON, DMM, Rakuten and many more. For more information:, Twitter: @Cxense. Cxense is listed on the Oslo Stock Exchange with the ticker ‘CXENSE.’ Investor Relations Contact: Jørgen Loeng, Chief Financial Officer Email: Mobile: +47 906 60 062

Change in Caverion’s Group Management Board: Martti Ala-Härkönen appointed as CFO

Change in Caverion’s Group Management Board: Martti Ala-Härkönen appointed as CFO Martti Ala-Härkönen (50), Dr. Sc. (Econ.), Lic. Sc. (Tech.), has been appointed as CFO of Caverion Group and a member of the Group Management Board of Caverion Corporation as of September 19,  2016. He will report to the interim President and CEO Sakari Toikkanen. Martti Ala-Härkönen’s latest position has been CFO of Cramo Group. Prior to that, he worked as CFO and SVP-Business Development of WM-data Oy and Novo Group Plc and in finance manager positions at Postipankki Plc. CFO Antti Heinola will leave the company as of September 30, 2016. “Antti Heinola has played a significant role in the establishment of Caverion and during the first three years. We have agreed together that it is a good time for the change of CFO now that our strategy period will be soon changing. I would like to warmly thank Antti for his contribution to the Group,” says Sakari Toikkanen. "Martti Ala-Härkönen is an experienced CFO with international knowledge of our industry. He has the combination of qualities that are needed in managing the company's financials in the near future and also over the longer term. I would like to warmly welcome Martti to Caverion,” says Sakari Toikkanen. The CV and the photo of Martti Ala-Härkönen are available on Caverion’s website at

The Descendant Now Available For Mac

“The Descendant plays great on Mac and we know many Mac owners love the Interactive Story Telling genre. We are happy to now include Mac players to our growing community.” Said Jean-Marc Broyer, President, Gaming Corps. THE DESCENDANT is a five-part episodic adventure game series, 3 Episodes have already been released with the 4th and 5th installment to be released before the end of the year. In THE DESCENDANT, the end of the world is only the start. With what remains of humanity protected in underground Ark facilities, your mission is to keep survivors alive, while discovering a far greater conspiracy buried within Ark-01. After climate change wrecked the planet, a man-made extinction event wiped humankind off the face of the Earth. Only a few thousand ‘descendants of humanity’ were hand-picked to survive the apocalypse, cryogenically suspended in underground bunkers known as Arks. Centuries passed. The world recovered from the nuclear holocaust, and all the Arks reopened, except one — Ark-01. Taking place across two timelines, in the past you'll play as Mia, a janitor tasked with keeping the precious descendants housed within Ark-01 alive while the facility continually fails around her, and in the present, you'll play as Donnie, one of the investigators trying to rescue any surviving descendants trapped within, all while discovering a far greater conspiracy buried within the underground Ark complex. Every action and choice you make directly impacts who lives and who dies, leaving the fate of Ark-01, and mankind itself, in your hands. Will you save mankind? Or doom us all? Key features · An episodic adventure spreading across multiple story-rich timelines · Investigative gameplay, challenging puzzles, tense action sequences · Meaningful and difficult choices with branching dialogue · A tailored experience, full of tension and drama · Every player choice can influence the future of mankind

Advenica launches secure cloud service in Norway which supports the new EU data protection law

Advenica’s solution provides a stronger protection of the subscriber, as well as for those who handle the registration or process the personal data, with a unique encryption solution for managing the sensitive information. The solution ensures that sensitive data is safely transferred from a municipality or authority to the actual storage, without the supplier being able to gain access to read or in any other way manipulate the information. “Handling personal data in a cloud service and not least in social media is a complex area. In the near future companies can be fined up to four percent of their global income and up to 20 million Euros if they don’t follow the new EU data protection law. At Advenica, we already offer services that prevents sensitive information that needs to be protected from ending up in the wrong hands”, says Einar Lindquist, CEO, Advenica AB. GDPR is relevant for companies that collect, process or store personal data. The law applies to companies operating in the EU and non-EU organisations – all those who have business relations with an organisation that’s active in the EU or stores data in any EU country. This is to ensure the protection being as comprehensive as possible for EU citizens.  The Data Protection Regulation will replace the former Data Protection Act (PUL) based on the previous EU directive Data Protection Directive (DPD). The aim of the new data protection regulation is to efficiently modernise data protection rules in the 28 EU member countries that have lagged behind in the digital development. In recent decades the technology has undergone a tremendous development and the time has come to introduce new revolutionary solutions that enable big savings and increase safety for the continuously increasing amount of data in the public sector. Today´s technology platforms make it possible to design solutions that can be a part of the foundation for national standardization, based on intelligent use of today´s standard solutions with a very high degree of flexibility regarding existing local solutions within the public sector. It’s a great advantage that already developed platforms (e.g. Altinn, Feide and HELFO) for different kinds of services can easily be integrated with Databankens services and products. “The services that Advenica offers are used by nations and their security organisations. We are very proud to be the first ones offering future-proof solutions for Norwegian municipalities and authorities which will be legislated in the EU in 2018”, says Ernst M. Carlsen, CEO, Databanken AS.  In October 2015 Advenica entered into a strategic cooperation with Databanken, which provides cloud-based solutions to their customers in Norway.  Based on guidance on information security by the Norwegian data protection authority, the Norwegian public sector has in the last 20 years built safe and secure solutions after their best capabilities with the available technology. This has resulted in hundreds of installations across the country that currently is operated, maintained, upgraded and renewed locally in 600 governmental, 19 county municipal and 428 municipal organisations within information and communication technology. About Databanken Databanken delivers secure cloud solutions. The concept is created and built by Technet Consulting AS who have more than 20 years of experience and skills as a supplier of services and products to government, county municipal and municipal users. Databanken combines and configures existing products from manufacturers like Advenica, HP, Microsoft, Citrix and VMware in a smart way with components from manufacturers of security and encryption technology. For further information, please contact: Einar Lindquist, CEO Advenica AB, +46 (0)704 29 98 39, einar.lindquist@advenica.comErnst M. Carlsen, CEO Databanken AS +47 95 22 83 22,                      The service can be ordered at Advenica’s website 

Bravida wins large installation contract when Uppsala University Hospital expands

Uppsala University Hospital, Akademiska sjukhuset, is about to be modernized. In the years leading up to 2023, the hospital will be equipped with both entirely new and renovated premises. Among other things, there will be an entirely new patient care building. Skanska has entrusted Bravida with all heating and plumbing installations in the new building. Sven Andersson, installation sourcing manager at Skanska, is pleased with the choice: – For Skanska, this is a project of considerable size, and the choice of supplier is largely a matter of trust. Bravida is a large company, and they have several similar projects in their track record. We can see that they have the capability of carrying out a project of this magnitude, he says. Bravida’s installations will include solutions for waste water, roof drainage, tap water, heating and cooling, among other things. The project started in the beginning of August and includes about 50 000 square metres of new hospital premises. The building will cointain 96 single patient rooms, 10 operating rooms, and a new medical health centre with a large number of consulting rooms, day care rooms and dialysis spots. There will also be an auditorium with a capacity for 130 people. – It’s great that Bravida has been entrusted with yet another hospital assignment. It points to our competencies in the area. This project will further deepen our cooperation with Skanska. At the same time, it enables our employees to further develop their skills in this type of installations, says Tomas Ekberg, Branch Manager at Bravida Heating and Plumbing in Uppsala. The project, which has a target order value of SEK 110 million, is estimated to be completed in August 2018. For further information, please contact:Tomas Ekberg, Branch Manager, Bravida Heating and Plumbing, Uppsala.Phone: +46 18-65 00 15Johan Brodin, Branch Manager, Bravida Region Uppland .Phone: +46 18-65 00 00

Welsh travel experts extend sponsorship of rugby giants

After Wales’ success in the European Football Tournament, the country is set to be gripped by their first sport as the Welsh Rugby season kicks off in September. And one company who can’t wait for the new season is holiday experts, Leisuretime. The leading provider of premier coach trips to the UK, Europe beyond, has extended its sponsorship of Merthyr RFC, one of the biggest clubs in Wales, and will be the title sponsor for the upcoming season, after previously partnering with the club over the last two years. Further cementing their long-standing relationship with the sporting team, the company is set to adorn the team’s shirts and work with them throughout the coming year. George Johnson, Director, said, “We are ecstatic to be extending our partnership with the team for the second year running. Rugby really is part of daily life for many here in Wales, and as one of the most successful businesses in south Wales, we are committed to giving back and supporting the community in South Wales and beyond.” Owned by Welsh businessman and property developer, Sir Stanley Thomas, Merthyr RFC had an incredible season last year. Finishing top of the WRU Championship, the team is now set to play in the Principality Premiership for the coming season. In order to get ready for their premier challenge, the team has lead the way and had a 4g pitch installed at their home, The Wern Sports Park. One of the first Welsh Rugby clubs to take the leap towards an artificial field, the players are ready and raring to go and tackle some of the finest teams in the world, including Newport, Cardiff and Ebbw Vale, and set to be thrust onto one of the biggest stages in rugby. Chanelle Murphy, Holiday Sales Consultant said “Our Coach Holiday Shop is located close to the Merthyr RFC ground in Merthyr town centre, so we can’t wait for the new season to kick off and hear the thousands of fans cheering on their local heroes.” To find out more about Leisuretime and the fantastic destinations they run holidays to, visit the website: Keep up to date on social media: Facebook: Twitter:

AcadeMedia publishes the Nomination Committee for the AGM in 2016

The Nomination Committee, which is appointed in accordance with the principles adopted by the Annual General Meeting December 18, 2015, consists of: · Erika Henriksson *, Marvin Holding Limited · Rune Andersson, Mellby Gård · Johan Lannebo, Lannebo Fonder · Ulf Mattsson * (Chairman of the Board) Chairman of the Nomination Committee is Rune Andersson. The Board of AcadeMedia AB (publ) ____________________________ For further information, see Shareholders who wish to submit proposals to the Nomination Committee for the Annual General Meeting November 17, 2016 may do so by sending an e-mail to Proposals shall, in order to be taken into consideration by the Committee, be submitted by 29 September, 2016. For more information, please contact:Christian Hall, Investor RelationsTelephone: 0763-111 242E-mail: About AcadeMediaAcadeMedia is the leading and single largest independent education provider in northern Europe. In 2014/15, approximately 62 000 children and students attended AcadeMedia’s preschools, compulsory schools and upper secondary schools. An additional 80 000 individuals participated in AcadeMedia’s adult education courses. In 2014/15, AcadeMedia had approximately 400 preschools, compulsory schools and upper secondary schools in Sweden and Norway and approximately 150 adult education units in Sweden. In February 2016, AcadeMedia also took a first step in the Company’s expansion outside Scandinavia through the acquisition of Joki, which operates seven preschools with approximately 450 children in the Munich region of Germany. AcadeMedia has operations throughout the education chain, from preschool, compulsory school and upper secondary school to adult education. More information about AcadeMedia is available on This information is information that AcadeMedia AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 10:00 CET on August 22 2016. * If more than one member of the Board is included in the nomination committee, only one of them should be dependent in relation to the major shareholders, according to the Swedish Corporate Governance Code. AcadeMedia has nevertheless selected Erika Henriksson and Ulf Mattsson to be part of the Nomination Committee.

Cherry-owned Game Lounge expands into Germany and UK through acquisition

In addition to incremental earnings, the acquisition will further strengthen Game Lounge’s position within the affiliate segment and take the step into the large German and UK markets, which are currently growing rapidly.The acquisition is fully financed through cash by Game Lounge operations and is expected to increase revenue with approximately €1,3m and EBITDA figures by more than €1m annually. The deal is expected to generate ROI in less than eighteen months. The acquisition will be integrated into Game Lounge’s existing operations and create new external affiliate-income and also support the Cherry brands.   Jonas Cederholm, CEO of Game Lounge, commented: “We are very happy to have reached an agreement with Interclick Limited, a company that has a long experience of affiliation. Both the German and UK markets are large and growing rapidly. The acquisition of the Interclick assets further accelerates our strategy and expansion beyond Scandinavia, and will be a beneficial contribution from day one.”   Fredrik Burvall, CEO of Cherry, commented: "The acquisition of the domains puts Cherry and Game Lounge in a stronger position in the affiliate sector, especially within the German and UK markets. We have been very pleased with the performance of Game Lounge so far, and this acquisition is very much in line with Cherry’s expansion plans. The affiliate market is an important part of the online gaming industry and Cherry continues to strengthen its online business with this acquisition.” For further information, please contact:Jonas Cederholm, CEO of Game Lounge Ltd, Telephone +356 991-70 863 Fredrik Burvall, CEO of Cherry AB (publ), Telephone +46 8-514 969 52, +46 709-279 632, Cherry in brief  Cherry is a Swedish gaming company established in 1963 specialized in online casinos and lotteries (,,,,, www.,,,,,,, and, affiliate business through Game Lounge and games development (, through subsidiaries in Malta. Cherry is the market leader in casinos in restaurants and nightclubs in Sweden. Cherry employs around 750 people and has more than 3,800 shareholders. The Company's B-shares are listed on AktieTorget.   

ESS Data Management and Software Centre Opens in Copenhagen

The research facility European Spallation Source ( (ESS) celebrates on August 26 the opening of the ESS Data Management and Software Centre (DMSC) permanent offices in Copenhagen. The Danish Minister for Higher Education and Science, Ulla Tørnæs, the Prorector for Research and Innovation at the University of Copenhagen, Thomas Bjørnholm, and the ESS Director for Science, Andreas Schreyer, will speak at the ceremony. Representatives from the Capital Region of Denmark, Confederation of Danish Industry (DI) and Danish ESS Partner Universities and Laboratories, such as DTU and Niels Bohr Institute, will among others attend the event. The Data Management and Software Centre (DMSC) in Copenhagen is a vital part of the European Spallation Source, currently under construction in Lund. DMSC will store and process the experimental data that will be generated at ESS. The DMSC staff is now developing software and hardware for the control, analysis, and visualization of the experiments to be carried out at ESS, in collaboration with partners at universities and research laboratories all over Europe. When ESS is in full operations, by 2025, DMSC will have 60-70 employees, mainly in Copenhagen. During the ceremony the official DMSC Door plate will be handed over to Mark Hagen, Head of DMSC. We cordially invite members of the media to attend the event and the following reception. Place: DMSC, COBIS, Ole Maaløes Vej 3, Copenhagen (, Date: August 26 Time:    10:15 Presentation DMSC and ESS for media - Mark Hagen, Head of DMSC             11:00 Messages of Congratulation             11:30 Hand-over of the DMSC Door Plate             11:40 1:1 media interviews             12:00 Reception

Leading online estate agent launches new website to give control back to homeowners

The UK’s leading online estate agent, I Am The Agent has shaken up what it means to sell or let a home online with a totally new look website which went live this week. The reinvigorated is a vibrant portal for homeowners, landlords, buyers and tenants, built on more than five years’ research and fuelled by feedback from 70,000 registered users. The new website has been carefully crafted to simplify the process of buying and selling a property. Bridging the gap between homeowners and their prospective buyers or tenants, expect powerful new features including the ability to highlight the best bits of a house or flat and 24/7 access to update selling points in the cloud, on the go and at home. Rebecca Peach, managing director of I Am The Agent, said, “Our vision is to make selling and renting a home simpler, clearer and cheaper with a professional, yet personal service that buyers and sellers alike can trust. We’ve worked with an expert team of web designers, marketers, property professionals and usability experts to take to new heights. It’s intuitive, functional and adaptive, packed with useful tools, equipped with full access to some of the biggest property portals in the world and backed by an in-house team of estate agents.” The new online portal provides users with a unique platform to creatively showcase their property. It follows the I Am The Agent ethos of ‘I Am Saving. I Am In Control. I Am The Agent’, and gives back control to homeowners so they can market their property as they see fit. I Am The Agent operates a no hidden costs or charges policy. Its completely transparent service encompasses a number of options for sales and lettings, with a range of packages and support levels to suit all budgets and selling or letting experience. It is committed to going above and beyond what other online-only estate agents offer. Advertising timescales are generous, with a year allowed for sales and up to six months for lettings. The estate agent also offers assisted viewings as an optional extra. The most popular sales package comes with free pro photos and floor plan or an EPC. Clients signing up to are assigned a dedicated property assistant who will guide the user through the process from start to finish, as well as arrange assisted viewings if required. Prices start at £19 to let, and £49 to sell. This makes them significantly cheaper than the industry average of £597, while giving users something extra – full control at the touch of a button. To find out more visit:

Citycon Oyj: Managers’ Transactions

Person subject to the notification requirement: Arnold de Haan, Member of the Board of DirectorsIssuer: Citycon Oyj, LEI 549300P8N0P6KDGTJ206Notification reference number: 549300P8N0P6KDGTJ206_20160819180003_3 1) TransactionsDate: 18 August 2016Venue: CHIXInstrument type: share, CTY1S  ISIN: FI0009002471  Nature of the transaction: acquisitionTransaction details(1) volume: 127, unit price: 2.27000 EUR(2) volume: 232, unit price: 2.27000 EURAggregated transactionsTotal volume: 359Volume weighted average price: 2.27000 EUR 2) TransactionsDate: 18 August 2016Venue: TRQXInstrument type: share, CTY1S ISIN: FI0009002471  Nature of the transaction: acquisitionTransaction details(1) volume: 766, unit price: 2.27000 EURAggregated transactionsTotal volume: 766Volume weighted average price: 2.27000 EUR 3) TransactionsDate: 18 August 2016Venue: BATEInstrument type: share, CTY1S ISIN: FI0009002471  Nature of the transaction: acquisitionTransaction details(1) volume: 1,500, unit price: 2.27000 EURAggregated transactionsTotal volume: 1,500 Volume weighted average price: 2.27000 EUR 4) TransactionsDate: 18 August 2016Venue: XHELInstrument type: share, CTY1S  ISIN: FI0009002471  Nature of the transaction: acquisitionTransaction details(1) volume: 4,000, unit price: 2.27000 EUR(2) volume: 222, unit price: 2.27000 EUR(3) volume: 778, unit price: 2.27000 EUR(4) volume: 222, unit price: 2.27000 EUR(5) volume: 1,000, unit price: 2.27000 EUR(6) volume: 900, unit price: 2.27000 EUR(7) volume: 1,290, unit price: 2.27000 EUR(8) volume: 193, unit price: 2.27000 EUR(9) volume: 835, unit price: 2.27000 EUR(10) volume: 782, unit price: 2.27000 EUR(11) volume: 1,000, unit price: 2.27000 EUR(12) volume: 981, unit price: 2.27000 EUR(13) volume: 1,000, unit price: 2.27000 EUR(14) volume: 1,430, unit price: 2.27000 EUR(15) volume: 589, unit price: 2.27000 EUR(16) volume: 600, unit price: 2.27000 EUR(17) volume: 786, unit price: 2.27000 EUR(18) volume: 300, unit price: 2.27000 EUR(19) volume: 46, unit price: 2.27000 EUR(20) volume: 3,268, unit price: 2.27000 EUR(21) volume: 5,000, unit price: 2.27000 EUR(22) volume: 1,219, unit price: 2.27000 EUR(23) volume: 820, unit price: 2.27000 EUR(24) volume: 1,300, unit price: 2.27000 EUR(25) volume: 1,661, unit price: 2.27000 EUR(26) volume: 143, unit price: 2.27000 EUR(27) volume: 753, unit price: 2.27000 EUR(28) volume: 1,577, unit price: 2.27000 EUR(29) volume: 870, unit price: 2.27000 EUR(30) volume: 1,800, unit price: 2.27000 EUR(31) volume: 1,914, unit price: 2.27000 EUR(32) volume: 2,461, unit price: 2.27000 EUR(33) volume: 29, unit price: 2.27000 EUR(34) volume: 625, unit price: 2.27000 EUR(35) volume: 227, unit price: 2.27000 EUR(36) volume: 4,773, unit price: 2.26800 EUR(37) volume: 126, unit price: 2.26800 EUR(38) volume: 357, unit price: 2.26800 EUR(39) volume: 1,498, unit price: 2.26800 EURAggregated transactionsTotal volume: 47,375 Volume weighted average price: 2.26971 EUR Helsinki, 22 August 2016CITYCON OYJ For further information, please contact:Anu Tuomola, General CounselTel. +358 50 414

Half-year Report January–June 2016

· Profit after tax for the period was SEK 1,649 million (1,221), equivalent to SEK 7.99 per share (5.92). The increase is due mainly to higher unrealized changes in the value of the property holdings. · Gross profit increased by 9 per cent, totalling SEK 616 million (565). The increase can be attributed largely to higher rental revenue. · Net revenue amounted to SEK 870 million (822), an increase of 6 per cent. · The fair value of the property holdings was SEK 33.7 billion (31.7 at the turn of the year), resulting in a net asset value of SEK 124 per share (118 at the turn of the year). Unrealized changes in value for the period totalled SEK 1,582 million (1,097). · The equity ratio was 60 per cent (58), the net loan-to-value ratio was 17 per cent (19), and the interest coverage ratio multiple was 8.3 (8.9). · The rental vacancy level at the period-end was 4.2 per cent (6.3). Excluding vacant space resulting from projects in progress, the rental vacancy level was 2.3 per cent (5.1).  Stockholm, August 22, 2016 HUFVUDSTADEN AB (publ)  Ivo Stopner President Appendix: Half-year Report January–June 2016  Questions can be answered by Ivo Stopner, President, or Åsa Roslund, Head of Finance, telephone +46 (0)8-762 90 00.   The information in this Interim Report is information that Hufvudstaden AB (publ) is obliged to publish under the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was published under the auspices of the above contact person on August 22, 2016 at 2:45pm. 

Nominations open for the Children's Climate Prize 2016

On a daily basis we hear politicians and scientists speaking about climate change; we hear about ocean acidification, stratospheric ozone, loss of biodiversity, chemical pollution, and aerosols in the atmosphere. Too seldom do we hear positive vibes and hope on the subject. Therefore the time has come to pay attention to the projects and initiatives coming from the next generation: children and young people in Sweden and around the world, climate heroes who refuse to believe in the dystopian predictions and who are fighting tirelessly for a sustainable future, in different ways and on different terms so that we all can live well and prosper in harmony with nature.  On Thursday 24th November 2016 the first ceremony of the newly instituted environmental prize, the Children's Climate Prize, takes place in Sweden. Another well-known Swedish award is the Nobel Prize, the most prestigious one of them all. The Children's Climate Prize is aiming just as high, therefore everything will be carried out just as it would be for the Nobel Prize with the prize ceremony in City Hall with accompanying banquet in impressive surroundings, with prominent guests from all over the world.  The winner of this year's Children's Climate Prize will be announced when chairman of the jury, Johan Kuylenstierna, opens the door to his office at the Stockholm Environment Institute. This will take place the week before the award ceremony.  There will be an opportunity for press and media to be present at the Stockholm Environment Institute for the announcement of this year's winner, please register your attendance with the press officer no later than 22nd October.About the Children's Climate PrizeThe prize is international and anyone can nominate or be nominated. The winner will receive a medal, a diploma and prize money of 50,000 Swedish kronor. The prize is awarded to a child or group of children, ages 10-16, who has, in an exemplary manner, made an extraordinary contribution to the climate and environment. Of all submissions, five will be selected by the jury and announced publicly in early November. One of the five will be the winner of the Children's Climate Prize 2016. The jury consists of Johan Kuylenstierna, director of the SEI, business economist and author Kjell A. Nordström, Sandra Jönsson from WWF Panda Planet, Katarina Mohlin from IF and Soledad Piñero Misa founder of Retoy. Children from France, USA and New Zealand, who participated in the Children's Climate Conference in 2015 will also participate in the jury, as well as students from Blombacka School, class 5, in Södertälje, Sweden. The award ceremony takes place on 24th November which is the anniversary of the Children's Climate Conference  ( the acclaimed climate meeting held in November 2015 in Södertälje, Sweden. When children from all over the world joined forces to put pressure on the world leaders ahead of the climate summit in Paris, COP21. To nominate your contribution to the Children's Climate Prize, please read more here.  ( Follow us in social media, hashtags #childrensclimateprize #ccprize #ccprize16  Children’s Climate Prize Facebook >> ( Children´s Climate Prize Twitter >> ( Children’s Climate Prize Instagram >> ( *On the photo from the left: Hanna Gorgis (Blombacka School, Södertälje, Sweden), Johan Kuylenstierna (Stockholm Environment Institute), McKenzie Royo (USA), Katarina Mohlin (IF), Sandra Jönsson (World Wildlife Foundation, WWF), Juliette Potier (France), Soledad Pinero Misa (Retoy), Melina Melkemichel (Blombacka School, Södertälje, Sweden), Kjell A Nordström (business economist and author) och Mikaira Hireme (New Zealand).

GomSpace (provider of nanosatellites) announces its quarterly results for the second quarter 2016.

Press release Stockholm 22 August 2016           GomSpace (provider of nanosatellites) announces its quarterly results for the second quarter 2016. Stockholm, August 22, 2016. GS Sweden AB announces its interim report for the second quarter of 2016. The report is available on the company’s homepage ( The following is taken from the quarterly report: Second quarter summary 1 April - 30 June 2016 (2015) · o    Successful trail of airline tracking in collaboration with Flightradar24 and Airbus Defence. · o    Investment collaboration with IFU on a major satellite project in Africa delivering a constellation of nano-satellites in order to establish a data service company. · o    Agreement signed with DALO and DTU on delivering a nano-satellite based surveillance demonstration for the Arctic. · o    Net revenues increased to SEK 13.9 million (8.0). · o    Gross margin increased to 66% (38%). · o    Profit/loss for the period increased to SEK 0.97 million (negative 2.24). · o    Earnings per share were SEK 0.09 (negative 3.2). 1 January - 30 June 2016 (2015) · o    Net revenues increased to SEK 24.9 million (13.1). · o    Gross margin increased to 65% (28%). · o    Profit/loss for the period increased to SEK 1.45 million (negative 5.84). · o    Earnings per share were SEK 0.25 (negative 8.35). “The result of the first half year of 2016 progressed satisfactory and within our expectations. Our investment program is expected to cause increased expenses and negative profit over the next years, however the underlying profitability seen in the obtained gross margin for GomSpace will stay strong”, CEO Niels Buus commented.     For more information, please contact:                     Niels Buus (CEO)Tel: +45 40 31 55 57                        Email:  Miscellaneous    +-----------------------------------------------------------------------------+|This information is information that GomSpace is obliged to make public ||pursuant to the EU Market Abuse Regulation. The information was submitted for||publication, through the agency of the contact person set out above, at ||[17:00] CET on August 22, 2016.   |+-----------------------------------------------------------------------------+ About GS Sweden AB The Company’s business operations are conducted through the wholly-owned Danish subsidiary, GomSpace ApS, with operational office in Aalborg, Denmark. GomSpace is a space company with a mission to be engaged in the global market for space systems and services by introducing new products, i.e. components, platforms and systems based on innovation within professional nanosatellites. The Company is listed on the Nasdaq First North Premier exchange under the ticker GOMX. FNCA Sweden AB is the Company’s Certified Adviser. For more information, please visit our website on

Viking Supply Ships AB announces changes in the financial calendar.

With reference to previous communication related to the ongoing financial restructuring of Viking Supply Ships A/S: The company has been in discussions with the ad hoc committee of bondholders, representing a majority of the outstanding bonds, regarding an adjusted proposal and has reached an in-principle agreement with the committee. It was expected that the necessary details and approvals of the overall restructuring would be in place to publish the financial report for Q2 2016 on Tuesday 23 August. However, there are still certain outstanding issues in connection with implementation of the global solution.  In order to give a more comprehensive and complete overview of the situation, Viking Supply Ships AB has hence decided to postpone the reporting date for Q2 2016.  The report was according to the financial calendar scheduled for 23 August. The new date for the report is 30 August at 08:30. In conjunction with the publication of the Q2 2016 report, an earnings call will take place on 30 August at 10:00 am (CET). For further information, please see: For further information please contact:   Ulrik Hegelund, CFO, ph. +45 41 77 83 97, e-mail  Morten G. Aggvin, IR & Treasury Director, ph. +47 41 04 71 25, e-mail  Viking Supply Ships AB (publ) is a Swedish company with headquarter in Gothenburg, Sweden. Viking Supply Ships A/S is a subsidiary of Viking Supply Ships AB (publ). In addition Viking Supply Ships AB (publ) has the subsidiary TransAtlantic AB. The operations are focused on offshore and icebreaking primarily in Arctic and subarctic areas as well as on Shipping services mainly between the Baltic Sea and the Continent. The company has in total about 500 employees and the turnover in 2015 was MSEK 1,977. The company’s B-shares are listed on the NASDAQ Stockholm, Small Cap segment. For further information, please visit:  This information is information that Viking Supply Ships AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 17:30 CET on 22 August 2016. 

Scania – driving the shift towards sustainable transport

The Sustainable Transport Forum in Paris underlines Scania's intention of leading the shift towards a sustainable transport system, a prerequisite for fulfilling the objectives of the Paris agreement and for achieving Sustainable Development. "When we launch the new generation Scania we want to take the opportunity to gather some of the most influential leaders to strengthen the global commitment to achieving sustainable societies," says Mr. Henrik Henriksson, CEO at Scania. Scania wants to use the Transport Forum to highlight the broader context within which we act, and show how the world can go from global agreements to global actions. We are getting closer to the point when it may actually be too late to act. "We need to bend the curve of global CO2 emissions within 4 years and then steeply reduce emissions to reach a fossil free world economy until 2050. For me, it’s no longer a question if humanity will move in a sustainable direction, but if we will manage to do it fast enough. The transportation sector plays a vital role in the transformation that has to happen," says Professor Johan Rockström, Director Stockholm Resilience Centre. Scania also wants to inspire the rest of the industry by focusing on opportunities arising from partnerships and by addressing the world’s next paradigm shift – moving from the industrial to the digital age – along with looking at what challenges need to be faced to achieve true sustainability. "When we look back in some twenty years time, I'm certain we will be able to say that the shift towards sustainable transports started here and that we were a part of the solution. I'm proud that Scania, together with our trusted partners, is leading the way towards a more sustainable future," says Mr. Henrik Henriksson. The Sustainable Transport Forum will be held at Grand Palais in Paris on Tuesday August 23, speakers include: · Mr. Kofi Annan, former secretary General of the UN · Mr. Georg Kell, Founding Director of the United Nations Global Compact · Mrs. Anna Johansson, Swedish Minister for Infrastructure · Mr. Andreas Renschler, Chairman Board of Directors Scania, CEO VW Truck & Bus · Mr. Michael Treschow, former Chairman of Unilever · Professor Johan Rockström, Director Stockholm Resilience Centre · Henrik Henriksson, CEO and President Scania To follow the launch and Forum through Scania’s channels, please visit: For further information, please contact Mr. Hans-Åke Danielsson, Press Manager Scania, tel. +46 8 553 856 62.

Gränges completes US acquisition

Gränges acquisition of Noranda’s downstream aluminium rolling business in the United States was closed today, on 22 August, 2016. In order to facilitate the acquisition, Danske Bank and Svenska Handelsbanken have provided Gränges with a credit facility. The acquisition is financed with a five-year term loan equivalent to USD 300 million. In conjunction with the acquisition, Gränges has also refinanced its existing revolving credit facility with a new three-year multi-currency revolving credit facility of SEK 1,200 million. The commitments under the Facilities Agreement are split equally between Danske Bank AS, Danmark, Sverige Filial, and Svenska Handelsbanken AB (publ). Svenska Handelsbanken AB (publ) is acting as Facility Agent for the facilities. For further information, please contact: Pernilla Grennfelt, Director Communications and IR of Grä, tel: +46 702 90 99 55 The information in this press release is such that Gränges must disclose pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on Monday, 22 August, 2016, at 21.30 CET. About GrängesGränges is a leading global supplier of rolled products for brazed aluminium heat exchangers. The company develops, produces and markets advanced materials that enhance efficiency in the customer manufacturing process and the performance of the final products; brazed heat exchangers. The company’s geographical markets are Europe, Asia and the Americas. Its production facilities are located in Finspång, Sweden, and Shanghai, China, and have a combined annual capacity of 220,000 metric tonnes. Gränges has some 950 employees and net sales in 2015 totalled SEK 5,494 million. The share has been listed on Nasdaq Stockholm since October 2014. More information on Gränges is available at

BAKKAFROST: Operational EBIT of DKK 307 million for the second quarter of 2016

The Bakkafrost Group delivered a total operating EBIT of DKK 307.1 million for Q2 2016. Harvested volumes were 13.0 thousand tonnes gutted weight. The combined farming and VAP segments made an operational EBIT of DKK 289.5 million. The farming segment made an operational EBIT of DKK 357.9 million and the increased salmon spot prices had a positive effect on the farming segment. The high salmon spot prices affected the VAP segment negatively, and the VAP segment made an operational EBIT of DKK -68.4 million. The EBITDA for the FOF segment was DKK 45.4 million. The total volumes harvested in Q2 2016 were 13.0 thousand tonnes gutted weight. Bakkafrost transferred 1.9 million smolts in Q2 2016. In Q2 2016, Havsbrún sourced 84.0 thousand tonnes of raw material. The farming segment made an operational EBIT of DKK 357.9 million for Q2 2016, which corresponds to NOK 34.47 per kg. The VAP segment made an operational EBIT of DKK -68.4 million for Q2 2016. The high spot prices in Q2 2016 had a negative effect on the operational EBIT in the VAP segment. The combined farming and VAP segments made an operational EBIT of DKK 289.5 million for Q2 2016, which corresponds to NOK 27.88 per kg. The FOF segment (fishmeal, oil and feed) made an operational EBITDA of DKK 45.4 million for Q2 2016. Commenting on the result, CEO Regin Jacobsen said: “We are very satisfied with the result for Q2 2016. The salmon spot price has been record high in the quarter and the biological performance has been good. The VAP segment has struggled, but we maintain our strategy to sell a share of our production as value added products. The development in our fishmeal, fish oil and fish feed segment in the quarter was also good. The five year investment plan was updated in June on our Capital Market Day, and the hatchery in Viðareiði is starting production at the moment, the new Harvest plant has started operation, and the construction of the new hatchery in Strond has commenced.” On 14 July 2016, Bakkafrost announced suspicion of pathogenic ISA virus in the farming site A-73 Hvannasund Norður based on regular ISA test results, carried out by the Veterinary Authorities according to the Faroese veterinary system. Consequently, Bakkafrost prepared to take necessary actions, and the Veterinary Authority undertook further tests in order to confirm the suspicion of pathogenic ISA virus. After a week of extensive testing, all the results were negative and did not prove the presence of pathogenic ISA virus. After that, the Veterinary Authority increased surveillance at the farming site A-73 Hvannasund Norður and carried out extra tests on neighbouring farming sites, which will be carried out for the next half year. This procedure is stipulated in the Faroese veterinary farming regime with the purpose of securing and maintaining good biology in the Faroese farming industry. Bakkafrost acquired the remaining outstanding shares (51%) in P/F Faroe Farming, effective from 1 July 2016. The Faroese Registry and the Competition Authorities have approved Bakkafrost’s acquisition of P/F Faroe Farming. Simultaneously, Bakkafrost filed (relinquished) two farming licenses to the Faroese Authorities. Following these two transactions, Bakkafrost has 14 licenses for farming salmon in the Faroe Islands. The Bakkafrost Group’s net interest bearing debt amounted to DKK 603.0 million at the end of Q2 2016. Bakkafrost had undrawn credit facilities of approximately DKK 642.8 million at the end of Q2 2016 and the equity ratio was 61% at 30 June 2016. OUTLOOK Market The global demand in the salmon market continues with strong growth rates. The market balance will be tighter in 2016, compared to 2015. Global supply of Atlantic salmon is expected to decrease by approximately 4% in volume during 2016, compared to 2015. The decrease is expected to be 8-9% in the second half of 2016. Production capacity is close to full utilization and further expansion relates to high investments. Farming The outlook for the farming segment is good. The estimates for harvesting volumes and smolt releases are as always dependent on the biological situation. Bakkafrost has acquired the remaining outstanding shares in P/F Faroe Farming, effective from 1 July 2016. P/F Faroe Farming is a salmon farming company and operates in the southern part of the Faroe Islands, Suðuroy. P/F Faroe Farming holds three farming licenses in Suðuroy, Faroe Islands, and the total harvested volumes for 2015 were 4,681 tonnes gutted weight, and the harvested volumes for H1 2016 were 2,054 tonnes gutted weight. P/F Faroe Farming will be consolidated into Bakkafrost Group from 1 July 2016. P/F Faroe Farming expects to harvest 1,000 tonnes gutted weight in the second half of 2016. Together with Bakkafrost’s unchanged expected harvest (excl. Faroe Farming) of 48,000 tonnes gutted weight, the total harvest for Bakkafrost Group in 2016 will be 49,000 tonnes gutted weight. The number of smolts released is one key element of predicting Bakkafrost’s future production. Bakkafrost forecasts a release of 10.4 million smolts in 2016, compared with 11.3 million smolts released in 2015 and 10.4 million smolts released in 2014. The biological situation is Bakkafrost’s most important risk area. The suspicion of possible pathogenic ISA virus in on of Bakkafrost’s farming sites on 14 July 2016 draws the attention to the importance of good animal welfare and biology to reduce the biological risk. Bakkafrost is focusing on the biological risk continuously and has made several new investments and procedures to diminish this risk. VAP (Value added products) Bakkafrost has signed contracts covering around 79% of the VAP capacity for the rest of 2016. This corresponds to around 39% of the expected harvested volumes for the rest of 2016. The remaining 21% are expected to be committed during the period. Bakkafrost has already signed contracts covering approximately 50% of the VAP capacity for 2017. In connection with the negotiation and signing of the new contracts for 2017, Bakkafrost has renegotiated the prices for part of the remaining quantities from the end of Q3 2016 in line with the forward price picture. FOF (Fishmeal, -oil and feed) The outlook for the production of fishmeal and fish oil is dependent on the availability of raw material. The quotas for catching blue whiting in the North Atlantic are expected to be reduced, and therefore the production of fishmeal and fish oil are most likely to reduce in volume in 2016 from relatively high volumes in 2015. Havsbrún’s sales of fish feed in 2016 are expected to be at 80,000 tonnes. Investments In June 2016, Bakkafrost announced a five-year investment plan from 2016 to 2020. The total investments for the period is DKK 2.2 billion, including maintenance CAPEX. The purpose of the investment plan is to continue to have one of the most cost conscious value chains in the farming industry, carry out organic growth, increase flexibility and reduce the biological risk to meet the future consumers’ trends and to be more end-customer orientated. Bakkafrost has a goal to be self-supplied with smolts at a size of 500g each. The benefits are a shorter production time at sea as well as reduced biological risk. To reach this goal, approximately half of Bakkafrost’s total investments over the next five years will be in hatcheries. The investment of the new harvest/VAP factory will be finalised in 2016. The harvest operation has started and the VAP operation is expected to start in Q4 2016. There will be some extra costs during the start-up period, but the investment is expected to result in operational savings of DKK 70-90 million per year with gradual effect from 2017. Bakkafrost plans to increase the value of offcuts from salmon harvested and processed in the new harvest/VAP factory. Bakkafrost will invest in a new salmon-meal and salmon-oil plant, located in Fuglafjørður and operated by Havsbrún. The FOF segment will also invest in a new feed line, which will increase the capacity of the feed production. Financial Improved market balances in the world market for salmon products and cost conscious production will likely improve the financial flexibility going forward. A high equity ratio together with Bakkafrost’s bank financing and the issuance of bonds makes Bakkafrost’s financial situation strong. This enables Bakkafrost to carry out its investment plans to further focus on strengthening the Group, M&A’s, organic growth opportunities and fulfil its dividend policy in the future. Please find enclosed the Company’s Q2 2016 report and presentation. Contacts: Regin Jacobsen, CEO of P/F Bakkafrost: +298 235001 (mobile) Gunnar Nielsen, CFO of P/F Bakkafrost: +298 235060 (mobile) This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. About Bakkafrost: Bakkafrost is the largest salmon farmer in the Faroe Islands. The Group is fully integrated from feed production to smolt, farming, VAP and sales. The Group has production of fishmeal, fish oil and salmon feed in Fuglafjørður. The Group operates licenses on 14 farming fjords. The Group has primary processing in Glyvrar, Kollafjørður, Vágur, and secondary processing (VAP) in Glyvrar and Fuglafjørður. The headquarter is located in Glyvrar, and the company has 765 fulltime employees. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES. This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities. The securities referred to herein may not be offered or sold in the United States absent registration or an exemption from registration as provided in the U.S. Securities Act of 1933, as amended. Copies of this announcement are not being made and may not be distributed or sent into the United States, Australia, Canada or Japan.

Multiconsult ASA second quarter 2016: Good earnings and improved order backlog

EBITDA for the quarter was NOK 92.0 million, an increase of 29.4 per cent compared to the same period last year. The increase is mainly explained by higher net operating revenues arising from the positive calendar effect, and contribution from LINK arkitektur AS. Higher operating expenses, which are in line with increased headcount, partly offset the positive effects. “I am pleased to see that the organization continues to deliver solid results in a competitive market. The new Tønsberg hospital contract award is of significant size and strategic value to us and confirms Multiconsult and LINK arkitektur’s position in the hospital market”, says CEO of Multiconsult ASA Christian Nørgaard Madsen. The order backlog improves at the end of the second quarter and was NOK 1 839.3 million, an increase of 15.0 per cent year on year. The increase is mainly driven by the large, strategic contract award for the new Tønsberg hospital, inclusion of LINK arkitektur AS on 30 September 2015 and solid growth from Transportation & Infrastructure. New contracts awarded during the quarter include the new hospital in Tønsberg, new bus transit lane in Stavanger, and Zanzibar energy sector support project among other. The majority of the order intake was related to new contracts, but important add-ons to and extensions of existing contracts such as Campus Ås and Radisson Blu Hotel Norge in Norway as well as Neelum Jhelum in Pakistan were also recorded in the quarter. Call-offs on frame agreements, such as the important Fosen wind project in Norway, are included when signed. Group balance remains solid as of 30 June 2016 with total assets of NOK 1 279.3 million and total equity of NOK 315.7 million. The group had cash and cash equivalents of NOK 50.0 million, while net interest bearing debt was negative NOK 40.1 million, i.e. an asset. The overall market outlook for 2016 remains fairly robust despite the slowdown in the Norwegian economy. Buildings & Properties is expected to have a modest, but stable growth. The outlook for the architecture market continues to be impacted by significant regional variations. Demand from the Oil & Gas industry is expected to continue at a low level as a result of lower oil prices and lower investment activity on the Norwegian continental shelf. Public sector investment is driving a strong outlook for Transportation & Infrastructure within road and rail. The Energy market remains strong in Norway, especially within transmission and hydropower. International renewable energy markets continue to grow, providing new business opportunities for Multiconsult. Multiconsult’s strong market position, flexible business model and wide service offering provides a sound base for further growth, both domestic and international. A presentation of the second quarter 2016 results will be held today, 23 August, at 09:00 CET at Felix Konferansesenter, Bryggetorget 3, 0250 Oslo. CEO Christian Nørgaard Madsen and CFO Anne Harris will hold the presentation. A live webcast from the presentation can be accessed at and For further information, please contact:    Investor relations:       Mirza Koristovic, Head of Investor Relations       Phone: +47 93 87 05 25       E-mail:    Media:       Gaute Christensen, VP Communications       Phone: +47 911 70 188       E-mail: ABOUT MULTICONSULT ASAMulticonsult is a leading Norwegian multidisciplinary engineering consulting company, with more than 2 200 employees and 45 offices in Norway and abroad. The Company focuses on seven market areas: Buildings & Properties, Transport & Infrastructure, Energy, Oil & Gas, Industry, Environment & Natural resources and Architecture. The Company has an operating history that spans more than a century, with the inception of Norsk Vandbygningskontor in 1908. In 2015 Multiconsult completed more than 9 000 projects for approx. 4 000 different customers. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Interim report Itiviti Group Holding AB January 1 – June 30, 2016

Steady earnings growth and momentum for new regulatory solutions · Operating revenue for the period from April to June 2016 was SEK 176,644k (170,060), an increase of 4% compared to the same quarter of 2015. Adjusted for foreign exchange effects, operating revenue rose by SEK 4,722k (3%), most of which is explained by the major sale of a perpetual license in the second quarter of 2016 and continued positive development in the APAC region. Product sales are already being driven by products built on our new technology platforms (Tbricks, Catalys) while Itiviti classic products remain stable.  · Adjusted EBITDA was SEK 88,573k (74,243) and EBITDA-CAPEX was SEK 40,105k (32,498). Operating expenses and adjusted CAPEX, adjusted for one-off effects, were SEK 1,023k lower than the same period last year. Adjusted for foreign exchange effects, expenses were SEK 3,618k higher than the same period last year, up by 3%. Most of the increase is explained by higher personnel costs, which have risen primarily due to an increase in the number of employees by around 30 and higher costs for sales commissions. This is offset somewhat by the fact that 2015 was affected by costs for an internal conference that was held in April 2015. The development of Itiviti’s new product offering to facilitate mandatory compliance with MiFID II and other regulations has resulted in higher development costs, which explains the increase in adjusted CAPEX. Comments from CEO Torben Munch: “The investment in our regulatory solutions offering is bearing fruit, as reflected in recent client wins for our market abuse product across Europe. As new regulations are introduced, we see market participants undertaking reviews of their legacy trading systems. As a global, proven and well-capitalized vendor, Itiviti is well positioned to meet the current and future requirements of existing and new customers. Our solutions are based on modern technology that is able to withstand and adapt to future challenges, both regulatory and commercial. To our clients, Itiviti thus offers confidence and certainty in these turbulent times, allowing a continued focus on their core business. Increasingly, clients are discovering the benefits of our new advanced modular technology, and we continue to drive migrations towards the Tbricks by Itviviti/Catalys by Itiviti platforms. In particular, we have signed a number of multi-year contracts with key clients, most of which resulted in broader relationships and demonstrating Itiviti’s commitment to long-term client partnerships. We are also excited about the launch of our new Itiviti website in July. Fully updated in both design and content, it is a source of information about Itiviti and our numerous ongoing initiatives, as well as industry and regulatory trends. The video channel ‘Itiviti Talks’ enables us to effectively share our staff’s wealth of knowledge with anyone interested in the forefront of our dynamic industry.” About ItivitiItiviti is a world-leading technology provider for the capital markets industry. Trading firms, banks, brokers and institutional clients rely on Itiviti’s technology, solutions and expertise to streamline their daily operations, while gaining sustainable competitive edge in global markets. With 13 offices serving more than 400 customers worldwide, Itiviti was formed by uniting Orc Group, a leader in trading and electronic execution, and CameronTec Group, the global standard in financial messaging infrastructure and connectivity. From its establishment in 2016, Itiviti has a staff of 400 and estimated annual revenue of SEK 700 million. Itiviti is committed to continuous innovation to deliver trading infrastructure built for today’s dynamic markets, offering highly adaptable platforms and solutions that enable clients to stay ahead of competitive and regulatory challenges. Itiviti Group Holding AB is owned by Itiviti AB, in which Nordic Capital Fund VII is the principal shareholder. For more information visit:

INTERIM REPORT, January–June 2016

Second quarter of 2016     · Consolidated net sales increased by 9 percent to SEK 522 m (481), of which organic growth amounted to 10 percent. Consolidated net sales were the highest ever for a second quarter. · Net sales in Product & Solutions amounted to SEK 397 m (377) and Installation Services to SEK 156 m (129) · Operating profit (EBIT) before items affecting comparability increased by 27 percent and amounted to SEK 84 m (66), which was the highest ever for the Group in a second quarter · Operating profit (EBIT) amounted to SEK 75 m (59) · Operating cash flow amounted to SEK 41 m (39) · Earnings per share before and after dilution were SEK 2.31 (1.62) January–June 2016 · Consolidated net sales increased by 6 percent to SEK 846 m (800), of which organic growth amounted to 7 percent. Consolidated net sales were the highest ever for a first half of a year. · Net sales in Products & Solutions amounted to SEK 656 m (630) and Installation Services to SEK 236 m (206) · Operating profit (EBIT) before items affecting comparability increased by 38 percent and amounted to SEK 96 m (70), which was the highest ever for the Group in a first half of a year. · Operating profit (EBIT) amounted to SEK 83 m (80) · In accordance with the usual seasonal variations, the operating cash flow was negative, in the amount of SEK -10 m (-21) · Earnings per share before and after dilution were SEK 2.32 (2.03) Message from the CEOStrong sales growth and significant improvement in earningsNordic Waterproofing Group’s business grew strongly in the second quarter of 2016, which was our first quarter as a listed company in the Mid Cap segment on Nasdaq Stockholm. Consolidated net sales rose by 9 percent and EBIT before items affecting profitability increased by 27 percent compared with the corresponding period in 2015.This performance, combined with our good first quarter, makes for a record first half year in the history of our Group, with sales up 6 percent and EBIT before items affecting profitability up 38 percent compared with the corresponding period in 2015. Our focus is on continuing to provide best-in-class customer service, product quality and logistics solutions. Our performance is driven by the expertise and high level of motivation among our workforce. We continue to look forward to a good full-year for Nordic Waterproofing Group.Nordic Waterproofing is one of Northern Europe's leading producers and providers of products and related services for waterproofing, protecting and preserving buildings and infrastructure.Consolidated net sales in the second quarter of 2016 showed growth of 9 percent compared to the corresponding period in 2015, from SEK 481 m to SEK 522 m, with both of our operating segments contributing. While our Products & Solutions operating segment picked up steam with a sales increase of 5 percent, our Installation Services operating segment reported a particularly strong performance with an increase of 22 percent, following an improving demand picture in Finland. Denmark continues to see a stable favorable demand trend. The Swedish market is continuing its robust development, although we noted a slightly weaker demand in the DIY sales channel, and in our sales of infrastructure project-related products. Our sales in Norway are back on track to a significantly positive growth trend, after a somewhat slower first quarter. The Finnish market has confirmed the early signs of growth seen since the beginning of the year, driven primarily by customers' projects in the Helsinki region.The Product & Solutions operating segment reported significant growth and an improved margin as the result of an increase in sales volumes combined with a continued focus on cost optimization. The period saw relatively low prices of oil and bitumen, albeit somewhat higher than during the first quarter.The Installation Services operating segment reported improved results, primarily due to better volumes in our Finnish operations. Our total order book for Installation Services remains at a high level compared to the corresponding period in 2015. The business in this operating segment is primarily conducted in Finland and through franchise companies in Denmark.In conclusion, we believe that the encouraging results obtained during the first six months of 2016 confirm the validity of our business model. We intend to continue strengthening our positions in our core markets, and evaluating growth opportunities in selected countries and market niches.Vejen, 23 August 2016 Martin EllisPresident and CEOConference callA conference call for investors, analysts and media will be held today at 10:00 a.m. CET and can be joined online at Presentation material for the call will be available on the website one hour before the call. To participate, please dial:From the United Kingdom:       +44 20 3008 9808From Denmark:                         +45 35 44 55 76From Sweden:                           +46 8 566 425 09 Further information can be obtained fromMartin Ellis, President and CEO, tel: +45 3121 3669Jonas Olin, CFO, tel: +46 708 29 14 54Anders Antonsson, Investor Relations, tel: +46 709 99 49 70This information is information that Nordic Waterproofing Holding A/S is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 23 August 2016, 08:00 p.m. CET.

Eltel’s power transmission business wins five new contracts in Finland at a total value of approximately EUR 18 million

The new contracts cover the following projects: · Extension of Fingrid’s 220/110 kV substation in Seitenoikea. The project will be completed by October 2017. · New 110/20 kV substation in Gunnarnäs, refurbishment and modernisation of the Vikom 110/20 kV substation and refurbishment and modernisation of the substations in Hanko, Lappohja and Lindsby as well as construction of the power lines Karjaa – Åminnefors and Karjaa – Lappohja, all for Caruna. The projects are planned for completion by the end of 2018. · Refurbishment of Elenia’s 110 kV power line Nivala – Hitura with new 2x110 kV line with a completion during summer 2017. Fredrik Menander, President – Power Transmission, Eltel AB comments:“These contracts confirm our strengthened market position for substations in the Nordics. Eltel is, since many years, one of the substation market leaders in Poland and we started the Nordic market entry with Finland in 2014. We have since then shown that Eltel is a competent and trustworthy partner to execute substation projects in Finland while executing other ongoing substation projects also in Sweden, Norway and Germany. Furthermore, we are very happy having been selected as the partner by Caruna and Elenia for their overhead line projects. The contracts above illustrate the continuous investments done in the grids in order to secure undisturbed transport of electricity”.  For further information:Ingela UlfvesVP – Investor Relations and Group CommunicationsTel: +358 40 311 3009,  Hannu TynkkynenDirector – External Communications and SustainabilityTel: +358 40 311 4503,   About EltelEltel is a leading European provider of technical services for critical infrastructure networks – Infranets – in the segments of Power, Communication and Transport & Security, with operations throughout the Nordic and Baltic regions, Poland, Germany, the United Kingdom and Africa. Eltel provides a broad and integrated range of services, spanning from maintenance and upgrade services to project deliveries. Eltel has a diverse contract portfolio and a loyal and growing customer base of large network owners. In 2015 Eltel net sales amounted to EUR 1,255 million. The current number of employees is approximately 9,600. Since February 2015, Eltel AB is listed on Nasdaq Stockholm.

Tele2 IoT acquires Kombridge AB and strengthens its position within security services

Kombridge brings a number of valuable assets and Tele2 IoT will immediately strengthen its security portfolio through the Kombridge Connect security product. The combined sales and technology teams will build upon Kombridge’s technology and knowledge to establish even stronger value added services for B2B application- and connectivity management. As part of the acquisition, Tele2 IoT obtains Kombridge’s current customer base, product portfolio as well as its six employees with great IoT competence and track-record to maximize sales and development synergies. Rami Avidan, Managing Director, Tele2 IoT, comments: “We are extremely excited to welcome the Kombridge team to the Tele2 IoT family. The two companies have worked close to each other for a long time. Hence, we know each other well and are very confident that our combined strengths will make us an even stronger global IoT player with high value creation for our customers and partners.” For more information, please contact:Viktor Wallström, Communications Director, Tele2 AB, Phone: +46 703 63 53 27Louise Tjeder, Head of Investor Relations, Tele2 AB, Phone: +46 704 26 46 52TELE2 IS ONE OF EUROPE'S FASTEST GROWING TELECOM OPERATORS, ALWAYS PROVIDING CUSTOMERS WITH WHAT THEY NEED FOR LESS. We have 16 million customers in 9 countries. Tele2 offers mobile services, fixed broadband and telephony, data network services, content services and global IoT solutions. Ever since Jan Stenbeck founded the company in 1993, it has been a tough challenger to the former government monopolies and other established providers. Tele2 has been listed on the NASDAQ OMX Stockholm since 1996. In 2015, we had net sales of SEK 27 billion and reported an operating profit (EBITDA) of SEK 5.8 billion.  For definitions of measures, please see the last page of the Annual report 2015.

Top line results from the Swedish ongoing Phase II study with IdeS in sensitized patients presented

The ongoing and fully recruited Phase II study at Uppsala University Hospital and Karolinska University Hospital in Huddinge, Sweden, includes 10 patients who received a single dose of IdeS (0.25 or 0.5 mg/kg) before kidney transplantation. The study’s primary focus is to evaluate safety and tolerability of Hansa Medical’s candidate drug IdeS in sensitized kidney transplantation patients. The study is also aimed at identifying an IdeS dose that results in anti-HLA antibody levels acceptable for transplantation within 24 hours from dosing.  Patients in the study are followed for six months after transplantation to continue to evaluate drug safety and kidney function.  The study is expected to be finalized in Q4 2016. Professor Tufveson concludes in his presentation that IdeS treatment is a suitable way to achieve rapid and effective desensitization allowing transplantation in immunized patients and that a dose level of 0.25 mg/kg body weight is a suitable dose. Two additional clinical studies with IdeS in sensitized patients are ongoing: an investigator initiated Phase II study at Cedars-Sinai Medical Center in Los Angeles and a pivotal multicenter study in the US with IdeS in refractory highly sensitized patients. Results from the multicenter study hold the potential to form the basis for filing a Biologics License Application, which is an application to the US Food and Drug Administration (FDA) for authorization to commercialize IdeS in the US. In addition, Hansa Medical is evaluating the possibility of adding various European sites to this multicenter study to better support the regulatory process at the European Medicines Agency, EMA, to gain marketing authorization of IdeS in the European market.  The information in this press release is disclosed pursuant to the EU Market Abuse Regulation. The information was released for public disclosure through the agency of the contact person stated below on  August 23, 2016 at 08.30 CET.

Going for Gold at Castle Howard – glistening crowning glory for famous dome

When complete, it will glisten in the sun to be seen from miles around.  That’s the promise from the Hon. Nicholas Howard to mark the start of the gilding process on the lantern which sits atop Castle Howard’s famous dome. Visitors to Castle Howard over the last couple of weeks will have seen scaffolding covering the lantern – the decorative feature which sits on top of the dome – as the wooden finial, cornice and windows of the lantern were prepared for the work, which will see sheets of 23.5 carat gold leaf applied to the woodwork to give an unrivalled shine.  The work can only be done in good weather to ensure that the gold leaf forms an effective shield against moisture – preserving the longevity of the cupola’s crown. “The lantern is the crowning glory which sits on top of Castle Howard’s dome, and when finished, the highly-reflective gold leaf will be visible from miles around,” explains Nicholas Howard, who has commissioned the work.  “In the past, different materials and techniques have been used to give the lantern its golden hue, but experience shows that only high quality gold leaf provides the glistening finish that can be seen in 18th century paintings of the building.” The gilding work will focus upon three sections – an apex finial which is just less than three metres high, the cornice and, below that, the lantern which has windows enabling the top of the dome to be a beacon by night as well as by day.  Although it may appear much smaller when viewed from ground level, the area to be gilded is approximately 32 square metres.  The sheets of gold leaf are painstakingly applied in sheets of 20cm square – up to 1000 will be used to complete the task – and fixed using a special oil-based adhesive.  “Approximately 1,000 sheets will be used, but the gold leaf is so thin that the entire weight of the gold used comes to a mere 16 grams.  This would be roughly equivalent to the weight of a medium-sized bracelet; or if it was rolled into a ball it would be a similar size to a marble.  The purity of the gold ensures that it will not tarnish, so there is no need to use a dulling sealant over the top – it will retain its shine and lustre for many years, whilst protecting the wood underneath from the elements,” adds Mr Howard. The dome is Castle Howard’s defining architectural element. The enormous lead-lined cupola rises up from the stone drum which is surrounded by a ring of gigantic busts. The apex to the building is the small wooden lantern above the cupola, which in turn has its own little cap topped by a large carved finial. The lantern and finial together stand five metres high.  The last time the dome was covered in gold leaf was in 1997, and before that in 1961 when the dome has been rebuilt after the fire of 1940. Subject to favourable weather conditions, the scaffolding should be removed in mid-to-late September, when the golden crown on the majestic building will be revealed once again. For more information, please visit ENDS Notes to editors: The gilding process is expected to take between a week and 10 days, and started on Thursday 18 August.  Prior to that, timber repairs and surface preparation – including painting the surface with a custard-yellow protective paint and filler – have taken place. The gilding is being undertaken by Hull-based Lightowler, which has two specialist gilders as part of its team. +----------+-----------------------+|Issued by:|Jay Commins, Pyper York|+----------+-----------------------+|Date: |23 August 2016 |+----------+-----------------------+|Telephone:|01904 500 698 |+----------+-----------------------+|Email: | |+----------+-----------------------+

Sino Agro Food Inc. Reschedules Conference Call

August 23, 2016 GUANGZHOU, China-- Sino Agro Food, Inc. (OTCQX: SIAF | OSE: SIAF-ME) Due to a late scheduling conflict, the Company has postponed its second quarter 2016 conference call to Friday, September 2, 2016 at 10:00 AM EDT/4:00 PM CET. The dialing instructions remain unchanged, as below. The Company appreciates your understanding and apologizes for any inconvenience resulting from this change. Earnings Call Information To participate in the conference call please use the following information: +-----------------------+-------------------------------+|SIAF 2016 Q2 Results ||Call Information |+-----------------------+-------------------------------+|Date: September 2, 2016|Time: 10:00 AM, EDT/4:00 PM CET|+-----------------------+-------------------------------+|Participant Dialing ||Instructions: |+-----------------------+-------------------------------+|SE:       +46 8 5059 63|UK:      +44 203 139 48 30 ||06 |CN:      +86 400 681 54 21 ||NO:      +47 23 50 05 | ||59 | ||US:      + 1 (866) 928 | ||-7517 | |+-----------------------+-------------------------------+|Conference ||Pincode 33780765#The ||earnings call will also ||be available over the ||web.To access, click ||the following link:  || Sino Agro Q2 2016 ||Earnings ||Call (https://wonderland || ||-18-sino-agro-food-q2 ||-report)   |+-----------------------+-------------------------------+

Scania introduces new truck range

Scania is introducing a new truck range, the result of ten years of development work and investments in the region of SEK 20 billion. With the new range, Scania is extending its offering and can now, thanks to its unique modular system, supply more performance stages, connectivity and a comprehensive palette of productivity-enhancing services as well as sustainable transportation solutions that are precisely customised for each type of customer in the highly comp­etitive transportation industry. The promise is that Scania's customers will always be able to carry out their work in the most sustainable and profitable way, regardless of industry and area of application. "It is undoubtedly the biggest investment in Scania's 125 year history," declares Henrik Henriksson, President and CEO of Scania. "It is with hearts bursting with pride that my colleagues and I are now presenting the products and services that will bring Scania to new levels regarding market shares and carry us far into the next decade. "Today we are not just launching a new truck range but also a unique, ingenious toolbox of sustainable solutions in the form of products and services that Scania is first in the industry to be able to deliver – and I feel I can claim this with confidence. We are focusing firmly on our main task: to give our customers the necessary tools for achieving profitability in the one business that really means something to them, namely their own." Production of the new trucks starts immediately at Scania's final assembly plant in Södertälje. Initially the focus will be on vehicles and services for long-haul transportation, but additional options will be continually introduced as more Scania plants readjust and additional options emerge. "There is a tremendous amount of development work by our engineers behind this introduction," emphasises Henrik Henriksson, Scania's President and CEO. "The most noticeable features are of course the new cabs, but the real innovation is that we are now introducing new technologies, services and insights that will help our customers gain an overview of both their costs and their revenues. Our goal is for our customers to be able to achieve sustainable profitability, regardless of assignment type or the conditions in which they work. Our customers' vehicles always constitute a link within the bigger picture; Scania embraces this through quality, accessibility and a range of physical or connected services. Our new range of products and services re­defines the term ‘premium’ within the truck industry." Scania is launching its new range in phases, with a clear focus on various customer segments and according to a carefully planned schedule. The introductions will continue after the first unveiling in Europe, with more customer options, before the entire process concludes with simultaneous launches on markets outside Europe. Among the improvements Scania is introducing, one that is particularly noticeable is a 5% reduction in diesel fuel consumption, thanks to factors such as improved powertrains and better aerodynamics. The express goal is for at least 40,000 customers and prospective customers to have test driven the new vehicles themselves in connection with the launches, and to have been introduced to Scania's entire range, covering everything from sustainability optimisation to financing, insurance and maintenance. Other channels are online communication, the media and Scania's approximately 1,700 dealers in more than 100 countries. The unveiling was held earlier tonight in Paris, live in front of roughly 1,500 special guests and globally to the online community. For further information, contact: Örjan Åslund, Head of Product Affairs, Scania Trucks, tel. +46 (0)70 289 8378, email 


Oslo, Norway, 24 August 2016 Nordic Nanovector ASA (OSE: NANO) announces its results for second quarter and half year 2016. A presentation of the results by the company’s senior management team will take place today at 8:30 a.m. CEST in Oslo - details below. Nordic Nanovector has continued to make good progress in executing its clinical development plan for Betalutin®. Patient recruitment is on track and all study sites have been recruited. Given this progress, Lymrit 37-01 study remains on track to define the optimized dose regimen to be used in PARADIGME, the pivotal Phase 2 study that is planned to start in 2H 2017. Updated data from this ongoing clinical study, presented at AACR in April, confirmed Betalutin®’s efficacy potential, durability of response and favourable safety profile in patients with advanced FL. The company continues to advance its product pipeline. Nordic Nanovector is ready to initiate its Phase 1 clinical study for Betalutin® in diffuse large B cell lymphoma (DLBCL) having received clearance of the Investigational New Drug (IND) Application from the FDA and acceptance of the protocol design from EU Authorities. Nordic Nanovector has signed two research and development collaborations with Paul Scherrer Institute and AREVA Med with the goal of developing new Antibody-Radionuclide-Conjugates (ARCs) for treatment of single cell leukaemias. The company has received a grant of up to NOK 15 million from the Research Council of Norway’s User-driven Research-based Innovation programme to support the discovery and development of novel targeted therapeutics for leukaemias and non-Hodgkin lymphoma (NHL). Luigi Costa, CEO of Nordic Nanovector, comments: “The first half of 2016 has been very positive for Nordic Nanovector and continues the positive momentum of 2015. We are pleased to report the continued good progress with the Lymrit 37-01 study as we remain on track to define the optimized dose regimen to be used in the pivotal Phase 2 study that is planned to start in 2H 2017. The updated results from Betalutin® in FL that were presented at AACR reinforce our belief in its promise to become a significant new treatment of NHL. We have also made good progress across all other key areas, including signing two new R&D collaborations to develop new ARCs for the treatment of leukemias.  We believe we are now well positioned to achieve our goal of becoming a leader in the development of targeted ARCs for haematological cancers.” Operational Highlights Q2 and First Half 2016 • Clinical study on Betalutin® in FL on track to meet timelines for selection of optimal dose regimen for the pivotal Phase 2 PARADIGME trial • Updated clinical results presented in April continue to show Betalutin®’s promising efficacy and increasing Duration of Response • Preparations towards initiation of clinical studies of Betalutin® in second NHL indication, DLBCL • Progress on advancing platform to deliver future pipeline products; R&D collaborations entered with Paul Scherrer Institute  and AREVA Med to develop new ARCs targeting leukaemias • New Chief Medical Officer signed on • Board of Directors strengthened further with international experts in development and commercialization of innovative cancer therapies Post Period Event • Completed recruitment of the first cohorts of Arm 3 and Arm 4 of expanded Phase 1/2 study of Betalutin® in NHL patients  Financial Highlights Q2 and First Half 2016 (Figures in brackets = same period 2015 unless otherwise stated) • Revenues for the second quarter amounted to MNOK 0.079 million (MNOK 0.142). Revenues for the first half of 2016 were MNOK 0.157 (MNOK 0.218). • Total operating expenses for the second quarter were MNOK 48.1 (MNOK 51.2). Total operating expenses for the first half of 2016 amounted to MNOK 100.9 (NOK 87.1) • Comprehensive loss for the second quarter amounted to MNOK 51.1 (loss of MNOK 47.7). Comprehensive loss for the first half was MNOK 115.2 (MNOK 81.4) • Cash and cash equivalents amounted to MNOK 618.4 at the end of June 2016 (MNOK 671.9 at 31 March 2016 and MNOK 743.4 at 31 December 2015) Outlook Nordic Nanovector is committed to develop, manufacture and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The market landscape for the company’s lead drug candidate Betalutin® is promising. Strong results and good progress in the Phase 1/2 study in addition to encouraging findings from the research and development pipeline bode well for Nordic Nanovector’s future. Management will continue to focus its efforts on the efficient execution of its plans and to meet anticipated clinical milestones. Current cash resources are expected to be sufficient to reach the first regulatory submission for Betalutin® in FL in the first half of 2019.     Presentation and webcast details A presentation by Nordic Nanovector’s senior management team will take place today at 8:30 a.m. CEST at: Thon Hotel Vika Atrium Munkedamsveien 45 0250 Oslo Meeting Room: NYLAND The presentation will be recorded as a webcast and will be available at in the section: Investor Relations/Webcast. The results report and the presentation will be available at in the section: Investor Relations/Reports and Presentation/Quarterly Reports/2016 from 7:00 am CEST the same day.  For further information, please contact: IR enquiries: Luigi Costa, Chief Executive Officer Cell: +41 79 124 8601 Tone Kvåle, Chief Financial Officer Cell: +47 91 51 95 76 Email: Media enquiries: Mark Swallow/David Dible (Citigate Dewe Rogerson) Tel: +44 207 282 2948/+44 207 282 2949 Email: About Nordic Nanovector Nordic Nanovector is a biotech company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology. The Company’s lead clinical-stage product opportunity is Betalutin®, the first in a new class of Antibody-Radionuclide-Conjugates (ARC) designed to improve upon and complement current options for the treatment of non-Hodgkin Lymphoma (NHL). NHL is an indication with substantial unmet medical need and orphan drug opportunities, representing a growing market worth over $12 billion by 2018. Betalutin® comprises a tumour-seeking anti-CD37 antibody, lilotomab (previously referred to as HH1), conjugated to a low intensity radionuclide (lutetium-177). The preliminary data has shown promising efficacy and safety profile in an ongoing Phase 1/2 study in a difficult-to-treat NHL patient population. The Company is aiming at developing Betalutin® for the treatment of major types of NHL with first regulatory submission anticipated in 1H 2019. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets, while exploring potential distribution agreements in selected geographies. The Company is committed to developing its ARC pipeline to treat multiple selected cancer indications. Further information about the Company can be found at Forward-looking statements This announcement may contain certain forward-looking statements and forecasts based on uncertainty, since they relate to events and depend on circumstances that will occur in the future and which, by their nature, will have an impact on Nordic Nanovector’s business, financial condition and results of operations. The terms “anticipates”, “assumes”, “believes”, “can”, “could”, “estimates”, “expects”, “forecasts”, “intends”, “may”, “might”, “plans”, “should”, “projects”, “will”, “would” or, in each case, their negative, or other variations or comparable terminology are used to identify forward-looking statement. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied in a forward-looking statement or affect the extent to which a particular projection is realised. Factors that could cause these differences include, but are not limited to, implementation of Nordic Nanovector’s strategy and its ability to further grow, risks associated with the development and/or approval of Nordic Nanovector’s products candidates, ongoing clinical trials and expected trial results, the ability to commercialise Betalutin®, technology changes and new products in Nordic Nanovector’s potential market and industry, the ability to develop new products and enhance existing products, the impact of competition, changes in general economy and industry conditions and legislative, regulatory and political factors. No assurance can be given that such expectations will prove to have been correct. Nordic Nanovector disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This information is subject to a duty of disclosure pursuant to Section 5-12 of the Securities Trading Act.

SCA plans to split the Group into two listed companies in 2017, hygiene and forest products

In August 2015, SCA announced that, in order to further develop the Group’s two operations, SCA had decided to initiate a dividing of the Group into two divisions: a hygiene division and a forest products division.  “For the Annual General Meeting 2017, the Board of Directors plans to present a proposal for the distribution and listing of the company's hygiene business”, says Pär Boman, Chairman of the Board of Directors of SCA. “Our hygiene and forest products businesses are two strong operations with attractive offerings in their respective industries. After a thorough analysis, our conclusion is that a split of SCA into two listed companies is the best way to continue to create shareholder value, customer benefits and further development opportunities”, says Magnus Groth, President and CEO of SCA. An evaluation, mainly based on value creation and flexibility for the shareholders, has been made of various methods and structural alternatives to achieve a complete split of the two businesses into two independent companies. The conclusion is that a distribution and listing of SCA's hygiene business will create more shareholder value and incur relatively low transactional risk and relatively low transaction costs. “It is the Board of Directors´ opinion that the proposal to split the hygiene and forest products businesses into two listed companies increases the ability for each business to successfully realize its strategies and increase value for SCA's shareholders. It is also pleasing that the main shareholders will support the proposal at the Annual General Meeting”, says Pär Boman Chairman of the Board of Directors of SCA. “As a long-term asset manager and active owner in SCA we share the company’s opinion that a dividing of the business creates value over time. It is a natural step in the successful streamlining towards the hygiene business and the forest products business conducted over several years, says Helena Stjernholm”, CEO, Industrivärden. Prior to the Annual General Meeting 2017, the Board of Directors plans to present a proposal for the distribution and listing of the Group's hygiene business. The distribution is proposed to be made to the shareholders in proportion to their holdings of SCA's Class A and Class B shares. The distribution is expected to meet the requirements of Lex Asea. If the shareholders decide in favor of the proposal, the plan is to distribute and list the new hygiene company on Nasdaq Stockholm during the second half of 2017. Following a split, there will be two listed companies. One will be a hygiene company including SCA's current business areas Personal Care and Tissue. The second, a forest products company including all forest products operations and all the forest land owned by the SCA Group. “SCA's leading global hygiene business offers products that make life easier every day for millions of people around the world. An increasing awareness of the relationship between hygiene and health, combined with a growing and aging population, are creating greater demand for hygiene products. Furthermore, SCA is Europe's largest private forest owner and the well-integrated supply chain, with production facilities concentrated in Sweden in close proximity to its forest holdings, offers significant synergies and competitive advantages. Forest Products is an efficient and well-invested business. Our investment in increased pulp capacity in the Östrand mill, one of the largest industrial investments in Sweden, will further strengthen our long-term competitiveness”, says Magnus Groth, President and CEO of SCA. Effective immediately, SCA's Directors appointed by shareholders and CEO, Magnus Groth, have, in addition to current assignments also been appointed the Board of Directors and CEO of the parent company for the hygiene business. The intention is to appoint Ulf Larsson, current President of SCA Forest Products and a member of the Executive Management Team, CEO of the listed forest products company after the distribution of the hygiene business. Effective immediately, the Board of Directors has also appointed Ulf Larsson, in addition to current assignments, Executive Vice President of SCA. The intention is that the new listed hygiene company receives a new name and is registered in Stockholm and the forest products company keeps the name SCA and is registered in Sundsvall. Conference call A conference call, held in English, for media, analysts and investors will be held today at 09:30 CET by Magnus Groth, President and CEO of SCA. The conference call will be live webcasted at You can also participate by telephone, call: +1 646 934 6795, +44 (0)207 1620 177 or +46 (0)8 5052 0114. Specify "SCA" or conference id 959885. Please call in good time before the conference starts. Facts SCAs businesses 2015 +--------------+----------------+------------------------+| |Hygiene business|Forest products business|+--------------+----------------+------------------------+| | | |+--------------+----------------+------------------------+|Net sales |SEK 98,528m |SEK 17,279m |+--------------+----------------+------------------------+|Adjusted |SEK 11,207m |SEK 2,605m ||operating | | ||profit1  | | |+--------------+----------------+------------------------+|Capital |SEK 68,201m |SEK 37,217m ||employed2  | | |+--------------+----------------+------------------------+|Average number|39,898 |4,153 ||of employees | | |+--------------+----------------+------------------------+|Sales in |Approx. 100 |Approx. 50 ||number of | | ||countries | | |+--------------+----------------+------------------------+|1Excluding | ||items | ||affecting | ||comparability | ||and common | ||Group expenses | ||2 Excluding | ||common Group | ||items | |+--------------+----------------+------------------------+ *Lex Asea is a tax regulation in Sweden. This provision means that if a parent company distributes shares in a wholly owned subsidiary to its shareholders, then the taxation of the capital gain the shareholders may enjoy in connection to the distribution under certain circumstances be postponed until the time when the shareholder in turn sells the received shares. NB: This information is information that SCA is obliged to make public pursuant to the EU Market Abuse Regulation or the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 07:30 CET on August 24, 2016. Karl Stoltz, Media Relations Manager, +46 8 788 51 55

Second quarter report 2016

24 August 2016 · Net sales increased by 12 percent to MSEK 1,503.5 (1,341.3), and by 15 percent at constant exchange rates. The increase refers mainly to Norway and Sweden. Net sales for comparable units, i.e. excluding Finland and Sødams in Denmark, increased by 12 percent at constant exchange rates. · Adjusted operating income* declined by 4 percent to MSEK 74.3 (77.0), corresponding to a margin of 4.9 (5.7) percent. Adjusted operating income increased in Norway and Sweden, but declined in Denmark. Adjusted operating income for comparable units increased by 11 percent. · Income for the period amounted to MSEK 38.8 (45.7) and earnings per share were SEK 0.65 (0.76). · Adjusted operating cash flow* declined to MSEK 33.1 (136.0) due to higher capital expenditure, which was also more phased to the first half of the year than in 2015, and an increase in working capital compared to a significant decrease in 2015. +-------------------------------+-------+-------+------+-------+-------+------+|MSEK |Q2 2016|Q2 2015|Change|H1 2016|H1 2015|Change|+-------------------------------+-------+-------+------+-------+-------+------+|Net sales |1,503.5|1,341.3| 12%|2,889.9|2,650.9| 9%|+-------------------------------+-------+-------+------+-------+-------+------+|Operating income | 74.3| 72.8| 2%| 141.5| 140.4| 1%|+-------------------------------+-------+-------+------+-------+-------+------+|Income for the period | 38.8| 45.7| -15%| 81.1| 87.3| -7%|+-------------------------------+-------+-------+------+-------+-------+------+|EPS, SEK | 0.65| 0.76| -15%| 1.36| 1.45| -6%|+-------------------------------+-------+-------+------+-------+-------+------+|Adjusted EBITDA* | 123.4| 123.8| -0%| 238.5| 237.8| 0%|+-------------------------------+-------+-------+------+-------+-------+------+|Adjusted operating income* | 74.3| 77.0| -4%| 142.6| 144.6| -1%|+-------------------------------+-------+-------+------+-------+-------+------+|Adjusted operating margin* | 4.9%| 5.7%| -| 4.9%| 5.5%| -|+-------------------------------+-------+-------+------+-------+-------+------+|Adjusted income for the period*| 38.8| 49.0| -21%| 82.0| 90.6| -10%|+-------------------------------+-------+-------+------+-------+-------+------+|Adjusted EPS*, SEK | 0.65| 0.82| -21%| 1.38| 1.51| -9%|+-------------------------------+-------+-------+------+-------+-------+------+|Adjusted operating cash flow* | 33.1| 136.0| -76%| 69.8| 236.3| -70%|+-------------------------------+-------+-------+------+-------+-------+------+ *) Adjusted for non-comparable items in Q2 2016 of MSEK - (-4.2) in EBITDA and operating income and MSEK - (-3.3) in income for the period, and for H1 2016 of MSEK -1.1 (-4.2) in EBITDA and operating income and MSEK –0.9(-3.3) in income for the period. See page 3. CEO Statement  Net sales showed strong growth in the quarter with an increase of 15 percent at constant exchange rates, which was significantly above the growth in the market. The increase referred mainly to additional distribution in Norway in combination with a strong recovery of the Norwegian market, strong growth in Sweden in chilled products and a significant number of new listings in Finland.   We successfully launched a number of new products in order to drive the category in line with our vision to inspire the Nordic consumers to eat chicken once more per week. These included for example tasty sausages, marinated barbeque products, inner filets on sticks and chicken bacon. Despite the strong growth in net sales, the adjusted operating margin for the Group declined from last year. This was mainly due to a decline in income for the Danish operation as well as costs for ramping up production in Finland. Furthermore the operation in Finland was included for the full quarter this year compared to only one month in 2015. We also had additional costs in Sweden to meet the strong demand and to maintain service levels at the same time as the Valla facility was rebuilt for higher capacity. Adjusted operating income for comparable units increased from last year. Adjusted operating cash flow declined as capital expenditure was higher than last year to secure capacity in Sweden and was also more phased to the first half of the year than in 2015. Working capital showed an increase compared to a significant decline last year. Net sales for the Swedish operation showed strong growth in chilled products and the Group strengthened its market share in this category. The adjusted operating margin was unchanged from last year as additional costs mentioned above had a negative impact. We are working on increasing both efficiency and capacity in production. The rebuilding of the Valla facility is expected to be finalised during the third quarter this year. The strong increase in net sales for the Norwegian operation referred to the new contract with COOP Norway. Deliveries under this contract started in August 2015. We also signed a new contract with NorgesGruppen earlier this year under which deliveries started in the first quarter 2016. The retail market for chicken products in Norway showed a continued recovery and grew by approximately 13 percent in value in the quarter compared to a decline by 4 percent last year. Adjusted operating income and margin for the Norwegian operation improved. The market share was strengthened from last year. Net sales for the Danish operation were higher than last year but the adjusted operating margin declined due to continued price pressure in both the local market and on exports. The majority of sales for the Danish operation refers to exports. Our efforts in product development will allow us to gradually expand our presence in the premium segment in the local market where Danpo is the leading brand, and also to offer more of further processed products for export. In the quarter we started to supply one of Europe’s leading foodservice providers with further processed products. As communicated in March, Mark Hemmingsen took over as new country manager as of August 1. I want to welcome Mark to the Group and I am convinced that his experience in consumer products and brand building will contribute to profitable growth for the Danish operation. Volumes for the Finnish operation more than doubled quarter over quarter as a result of new and extended customer contracts. The retail market for chicken products in Finland grew by approximately 14 percent in value in the quarter compared to last year. Adjusted operating income remained negative, however, due to additional costs for handling inefficiencies and bottlenecks in production as volumes were significantly ramped up to meet demand. We are taking a number of actions to improve productivity in the facility and expect to see a gradual improvement over the coming quarters. We expect continued good growth in market demand and have great opportunities to grow net sales and develop the category. We are working hard to take advantage of this growth and at the same time improve the Group's results and financial position. Leif Bergvall HansenManaging Director and CEO Further informationFor further information, please contact: Leif Bergvall Hansen, Chief Executive Officer Tel: +45 22 10 05 44Tobias Wastensson, Head of Group Finance Tel: +46 10 456 14 86    Financial calendar ·  Interim report for the third quarter 2016: 3 November 2016 This interim report comprises information which Scandi Standard is required to disclose under the Securities Markets Act and/or the Financial Instruments Trading Act. It was released for publication at 07:30 CET on 24 August 2016.

David Nuutinen steps down as CEO – search for new CEO initiated

“David Nuutinen has been a successful and appreciated leader in Cloetta during his thirteen years with the company, including the last year as CEO. Therefore, I very much regret that he has decided to leave Cloetta and on behalf of the Board I would like to express our sincere thanks and appreciation to David for his dedication and excellent work for the company”, says Lilian Fossum Biner, Chairman of the Board of Directors. “I am very pleased with Danko Maras taking the role as interim CEO. He is very experienced and has been with the company for many years and will together with the Group Management Team make sure that we continue to drive profitable growth. Strategy and financial targets therefore remain intact”, says Lilian Fossum Biner. David Nuutinen will be available to support the Board and the management team during his term of notice of six months. Conference callA conference call with Lilian Fossum Biner, Chairman of the Board of Directors, David Nuutinen, outgoing President and CEO, and Danko Maras, incoming interim President and CEO will be held today at 10.00 a.m. Those who wish to participate are invited to dial in on telephone number +46 8 566 426 95. The presentation will be in English. Make sure that you are connected to the conference by dialing in and register a few minutes before the conference begins. An audio recording of the conference call will be published on This information is information that Cloetta AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on 24 August 2016 at 08.00 a.m. CET.

WntResearch announces organizational changes

By the instalment of the position as Chief Technical Officer and by the recruitment of Dennis Henriksen, the company strengthens its in-house competence and resources within the areas of regulatory affairs, clinical trials, production planning and intellectual property. Dennis Henriksen (b. 1962), M.Sc. in chemical engineering from the Technical University of Copenhagen and Ph.D. in bioorganic chemistry from the University of Copenhagen, has held leading positions in biotech companies for more than 20 years. He has great experience in the processes of research, development, registration and commercialization of pharmaceuticals and has, among other positions in the past, worked as VP for BioNebraska Inc in the United States, where he was responsible for the company’s R&D. Dennis Henriksen will take up his new position with immediate effect. “We are happy to welcome Dennis Henriksen to WntResearch. His experience and competence will strengthen the company in the preparations for the coming phase 2-study of the drug candidate Foxy-5 and in the continuing preclinical work with the drug candidate Box-5,” says Henrik Lawaetz, CEO, WntResearch. Furthermore, WntResearch announces that Chief Medical Officer Nils Brünner has declared that he will be leaving the company by the end of 2016. Nils Brünner will turn 65 in the beginning of 2017 and with the increased workload that is associated with the preparations and implementation of the planned phase 2-study of the drug candidate Foxy-5, the company and Nils have jointly determined to start the process of finding a successor. Nils Brünner has been active in WntResearch since 2008 and has played a key role in the company’s development. He will be proposed as a new member of the company’s Board of Directors. For further information contact: Henrik Lawaetz, CEOE-mail: hl@wntresearch.comTelephone: +46 72 702 4694 About WntResearch WntResearch is developing a new type of cancer treatment based on pioneering research, which shows that the endogenous protein Wnt-5a plays a crucial role for tumour cells’ ability to relocate and spread inside the body. Most patients that die of cancer do so not due to the primary tumour, but due to metastasises and the need for a specific treatment to counteract metastasis is therefore in high demand. WntResearch’s most advanced drug candidate Foxy-5 has in preclinical tests been shown to reduce tumour cells’ mobility and thereby counteract the occurrence of metastasis. The results from a completed phase 1-study show a favourable security profile and pharmacokinetics as well as early indications of biological activity. A phase 1b-study is currently ongoing in patients with cancer in colon, prostate and breast. WntResearch is a public company listed at AktieTorget in Stockholm, Sweden. For further information:  

Immunovia Half-year report 2016

“Immunovia reached several important milestones in the first six months of 2016. Good results were obtained in the American pancreas study that was carried out in collabo­ration with Knight Cancer Institute. Presentations made at the key global conferences concerning pancreatic cancer were very well received. A specially strong Scientific Advisory Board has been recruited, and involvement from the patient organization has increased. Furthermore, several significant agreements were signed with important cancer centres. The market introduction of IMMray™ PanCan –d, Immunovia’s diagnosis test for early detection of pancreatic cancer, is expected to begin in 2017 and then generate income from the hereditary risk groups in 2018. It is planned to start pancreatic cancer tests for the diabetes group soon afterwards. In addition, it will be possible to use the test for patients seeking help with vague symptoms and where there is a need to swiftly rule out pancreatic cancer. In the second half of 2016 Immunovia’s laboratory in Lund is expected to be completed and subsequently accredited for ISO certification in 2017. CE labelling of IMMray™ PanCan –d will be concluded in 2017. It will then be possible to receive samples from all over Europe to establish early detection of pancreatic cancer, with talks already being held with several prospective customers, i.e. cancer centres and laboratories. In mid-August Immunovia announced its intention to seek a listing on Nasdaq Stockholm’s Main Market in 2017.” Key Indicators +----------------------+-----------------+-----------------+-------------+|Key   Indicators  |1 Jan-30 Jun 2016|1 Jan-30 Jun 2015| 2015 ||(SEK 000 unless | | | Full year ||otherwise stated) | | | |+----------------------+-----------------+-----------------+-------------+|Net   sales | 66| 59| 205|+----------------------+-----------------+-----------------+-------------+|Operating   earnings | -5 403| -3 836| -7 424|+----------------------+-----------------+-----------------+-------------+|Earnings   before tax | -5 298| -3 807| -7 384|+----------------------+-----------------+-----------------+-------------+|Net earnings | -5 298| -3 807| -7 384|+----------------------+-----------------+-----------------+-------------+|Earnings   per share | -0,38| -0,34| -0,65||before dilution | | | ||(SEK/share) | | | |+----------------------+-----------------+-----------------+-------------+|Earnings   per share | -0,36| -0,33| -0,62||after dilution | | | ||(SEK/share) | | | |+----------------------+-----------------+-----------------+-------------+| | | | |+----------------------+-----------------+-----------------+-------------+| | 30 Jun 2016  | 30 Jun 2015  |31   Dec 2015|+----------------------+-----------------+-----------------+-------------+|Equity   ratio, % | 93| 84| 92|+----------------------+-----------------+-----------------+-------------+|Gearing   ratio, times| 0,07| 0,19| 0,09|+----------------------+-----------------+-----------------+-------------+ Outlook*Immunovia is focused on fundamentally transforming diagnosis of complex forms of cancer and autoimmune diseases. The antibody-based platform, IMMrayTM, is the result of 15 years of research at CREATE Health – the Center for Translational Cancer Research at Lund University, Sweden. IMMray™ is a technology platform for the development of diagnostic tests and the company’s primary test, IMMray™ PanCan-d, is the first test in the world for early diagnosis of pancreatic cancer. ·  It is planned to launch IMMray™ PanCan-d on the American and European markets with sales start in 2017 to out-of-pocket customers, with revenues expected to begin in 2018. In coming years Immunovia will address a market that in total is worth around SEK 30 billion. ·  Immunovia sees great potential in the development of tests for other unsolved problems in cancer and autoimmune diseases via its IMMray™ platform. The next focus area will be tests within SLE. *No changes compared with the Financial Statement dated 24 February 2016. For further information, please contact:Mats Grahn, CEO, Immunovia ABPhone: +46 (0) 70-532 02 30E-mail:  About ImmunoviaImmunovia AB was founded in 2007 by investigators from the Department of Immunotechnology at Lund University and CREATE Health, the Center for Translational Cancer Research in Lund, Sweden. Immunovia’s strategy is to decipher the wealth of information in blood and translate it into clinically useful tools to diagnose complex diseases such as cancer, earlier and more accurately than previously possible. Immunovia´s core technology platform, IMMray™, is based on antibody biomarker microarray analysis. The company is now performing clinical validation studies for the commercialization of IMMray™ PanCan-d that could be the first blood based test for early diagnosis of pancreatic cancer.  In the beginning of 2016, the company started a program focused on autoimmune diseases diagnosis, prognosis and therapy monitoring. The first test from this program, IMMray™ SLE-d, is a biomarker signature derived for differential diagnosis of lupus, now undergoing evaluation and validation. (Source:  Immunovia’s shares (IMMNOV) are listed on Nasdaq First North in Stockholm and Wildeco is the company’s Certified Adviser. For more information, please visit ###

Nanologica enters into research collaboration with GSK

”We are excited about the collaboration with GSK. This is an early, but interesting project with the possibility to unlock new approaches to personalized medicine. It is a great opportunity for Nanologica to contribute to this field,” says Nanologica’s CEO Andreas Bhagwani. This paid development project is in line with Nanologica’s strategy in the business area Drug Delivery. The business model in Drug Delivery is based on having many different projects in collaboration with pharmaceutical companies to apply Nanologica’s proprietary technology to real problems of drug developers. Nanologica is increasingly seeking projects where potentially more value can be created, as this agreement illustrates. “The healthcare industry is showing growing interest in Nanologica’s technology, which for us is good evidence that we are on the right track. Our goal is to be the world-wide expert in porous silica-based materials for life science applications,” says Andreas Bhagwani. Early projects can be the starting point of long-term collaborations, but can also be limited to the initial scope and timeline. Nanologica is constantly evaluating new project proposals with the goal to identify opportunities to apply and commercialize its drug delivery systems. For further information, please contact: Andreas Bhagwani, CEO of Nanologica phone: +46 70 316 17 02 or e-mail: About Nanologica Nanologica develops nanoporous silica for applications in life science. The company focuses on two business areas: drug delivery and chromatography, a technology used for the separation and purification of products on the market and in development. Nanologica’s core competency is to apply its unique know-how in the field of material science for developing nanoporous silica particles with unique characteristics. Based in Södertälje, Sweden, Nanologica has 19 employees from ten nationalities of which ten are PhDs. For more information, please visit

NeuroVive’s Chief Operating Officer Jan Nilsson leaves the company

The company is entering into a very important period and is expecting exciting developments during the fall. Over the past several months, the business strategy and organization have been re-oriented to optimize the way forward. As one consequence the position of COO is no longer required. “I have been involved in NeuroVive in different roles since 2010 and it has been fantastic to be part of the development of the company to the position it holds today. The company has a very interesting project portfolio and a strong organization. The transition to our new CEO is now concluded which makes the timing right for me to seek new challenges. I will of course follow the company’s continued development with greatest interest”, says Jan Nilsson. “Jan Nilsson has with great dedication, in combination with his vast knowledge and experience, played a key role in NeuroVive, not only as COO but also as a Director and for a period as interim CEO. Jan has been instrumental in managing the challenges faced by NeuroVive in recent years. On behalf of the entire company and its shareholders, I express our respect and appreciation for Jan and wish him all the best in his new endeavors”, says Greg Batcheller, Chairman of NeuroVive. About NeuroVive NeuroVive Pharmaceutical AB (publ) is a pioneer in mitochondrial medicine and a company committed to the discovery and development of highly targeted candidates that preserve mitochondrial integrity and function in areas of significant therapeutic need. NeuroVive's business approach is driven by value-adding partnerships with mitochondrial research institutions and commercial partners across the globe. NeuroVive's portfolio consists of two clinical projects, one in acute kidney injury (CicloMulsion®) and one in traumatic brain injury (NeuroSTAT®). The candidate drug NeuroSTAT has orphan drug designation in Europe and in the US for treatment of moderate to severe traumatic brain injury and is currently being evaluated in the CHIC study. CicloMulsion is being evaluated in an on-going study, CiPRICS, in acute kidney injury during major surgery. Furthermore, the R&D portfolio consists of two late stage discovery programs and one compound in preclinical development. NeuroVive is listed on Nasdaq Stockholm, Sweden, Small Cap, under the ticker symbol NVP. The share is also traded on the OTC Markets Group Inc market in the US. NeuroVive Pharmaceutical (OTC: NEVPF) trades on the OTCQX Best Market. For investor relations and media questions, please contact:  Cecilia Hofvander, NeuroVive, Tel: +46 (0)46 275 62 21 or  NeuroVive Pharmaceutical AB (publ)Medicon Village, SE-223 81 Lund, SwedenTel: +46 (0)46 275 62 20 (switchboard), Fax: +46 (0)46 888 83   This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 a.m. CEST on August 24, 2016.  

Cantargia interim report January – June 2016

Significant events in the second quarter  · The exercise period for warrants of series TO 1 and TO 3 began on 23 March 2016 and ended on 13 April 2016. In total, 4,127,260 warrants of both series were exercised, representing around 83.5 per cent of the number of warrants issued. Through the warrants Cantargia raised approximately SEK 31.4 million before issue costs.  · During the period the Company gave investor presentations at the international BioEquity conference in Copenhagen on 10 May 2016 and at the Småbolagsdagen small cap investor event at the Sheraton Stockholm Hotel on 13 June 2016.  · The annual report for the financial year 2015 was published on 29 April 2016. The company held its Annual General Meeting on 25 May 2016 and published a report on the AGM the following day. The annual report and AGM report are available for download on the company’s website,  · Cantargia received a Notice of Allowance from the US Patent Office for IL1RAP as target molecule for antibody-based treatment in acute lymphoblastic leukemia followed by a Notice of Allowance for IL1RAP as target molecule for antibody-based treatment in solid tumours from the same patent office. The company also received formal approval in Japan of a patent for solid tumours.  · The company announced that its CAN04 product candidate has been shown to have a high level safety in high doses – repeated treatment with up to 100 mg/kg. During the period Cantargia also decided that the company will conduct further process development studies to establish a strong foundation for long-term production and that the start of the GLP toxicity study will therefore be postponed until autumn 2016. Consequently, the start of clinical studies will also be postponed until the end of the first quarter of 2017.  · A third party filed an opposition to Cantargia’s patent in Europe for IL1RAP as a target molecule for antibody treatment and leukemia diagnostics. Cantargia will be working with its patent agents and the European Patent Office to conduct the process in a professional and correct manner. Significant events after the end of the period  · In July Cantargia announced that the US Patent Office had approved the company’s application for IL1RAP as target molecule for antibody-based treatment of solid tumours. · In August Cantargia announced that the company’s former CEO, Agneta Svedberg, has exercised 1,250 warrants of series 2011/2016. The exercise of the warrants will raise SEK 250,212.50 for Cantargia. Financial information First half (1 Jan 2016 – 30 Jun 2016)  · Other operating revenue was kSEK 0 (0).  · Earnings after financial items were kSEK -16,023 (-9,059).  · Earnings per share were approximately SEK -0.91 (-0.68).  · The equity/assets ratio was around 87 (89) per cent compared with the beginning of the year.  Second quarter (1 Apr 2016 – 30 Jun 2016) · Other operating revenue was kSEK 0 (0).  · Earnings after financial items were kSEK -7,926 (-5,432).  · Earnings per share were approximately SEK -0.45 (-0.41).  Definitions  · Earnings per share: Profit for the period divided by 17,633,134 shares as at 30 June 2016. · Equity/assets ratio: Equity divided by total capital.  · Unless otherwise indicated, figures in parentheses refer the same period in the previous year.  For further information, please contact Göran Forsberg, CEOTelephone: +46 (0)46 275 62 60E-mail: goran.forsberg@cantargia.comCertified Adviser: Sedermera Fondkommission  This constitutes information that Cantargia is required to publish under the EU’s Market Abuse Regulation. The information was submitted for publication through the above contact person at 8:30 (CEST) on August 24, 2016. 


“This acquisition will make HiQ’s position even stronger and more relevant – it’s a great enhancement to our existing team of experts within the digital area. This will enable us to move even faster when solving our client’s challenges, all the way from idea to realisation and within the entire chain of people, technology, and business,” says Lars Stugemo, President and CEO of HiQ. Great Apes has a lot in common with HiQ and isn’t afraid to challenge existing ways of doing things. Some of the clients are Linnanmäki, Microsoft, Lidl, Amer Sports, Royal Ravintolat, Paulig Group, the Finnish Defence Forces, and Veikkaus. Great Apes is also one of the most internationally awarded digital agencies in Finland, with repeated recognition from industry-leading competitions such as The Webby Awards, Red Dot Design Awards, and Eurobest, as well as Nordic awards such as Grand One and Grafia’s Best of the Year.  “We are happy to join forces with HiQ. This will give us a lot more body and we look forward to being able to work with larger, more advanced, and game-changing projects,” says Mikko Sairio, partner and one of the three founders of Great Apes.  “I’m happy to welcome Great Apes into the HiQ team. Both HiQ and Great Apes have a strong customer base, and together we can take on even bigger assignments, using technology to create a better and more joyful world. Great Apes is a great match both competence- and culture wise. They share HiQ’s values and are a group of great people; result oriented and with a positive energy,” Stugemo concludes. In relation to the closing on 31 August, 257 832 HiQ shares will be issued, corresponding to a dilution of 0,5 %. Great Apes is expected to make a positive contribution to HiQ’s profit right from the start, and also to its earnings per share. For more information, please contact: Lars Stugemo, President and CEO of HiQ. Tel. +46 8 588 90 000 Jenny Normark Sperens, Head of Corporate Communications. Tel. +46 734 431 007

Leading construction company Sanken Overseas Pvt Ltd selects IFS Applications 9

The company chose IFS Applications to ensure access to improved management information, project profitability information, enhanced stock and employee management as well as management of subcontracting work. The IFS solution purchased by Sanken Overseas (Pvt) Ltd includes finance, supply chain, project management, and human resource capabilities and will be used by 233 employees across the organization’s geographically dispersed operations in Sri Lanka, Maldives, Seychelles, Kenya, Uganda, and Myanmar.  “Sanken is pleased to work with IFS and we look forward to deploying a fully-fledged ERP suite.” said Mr. B. B. Kulupana, Managing Director/CEO of Sanken Overseas (Pvt) Ltd. “Rapid growth of our overseas business has brought on many management challenges, which we hope the IFS solution will help us overcome and transform into an opportunity that can have a positive bearing on our margins and profitability.” Mr. Jayantha De Silva, President/ CEO of IFS Sri Lanka added, “IFS has a proven track record in the construction industry globally and we are happy to be able to embark on yet another construction implementation, this time together with a Sri Lankan company. IFS Applications is a user-friendly and easily adaptable ERP suite that I am sure will be well received by Sanken’s user base. Our experienced team of consultants and I look forward to completing yet another successful implementation.”

Nel ASA: Launches new containerised, turn-key electrolysers

(Oslo, 24 August 2016) Nel Hydrogen Electrolyser, a division of Nel ASA (Nel), today launches the new containerised NEL C-range electrolysers, thereby offering a low-cost, turn-key solution, representing the world’s smallest footprint for containerized, high capacity electrolysers. “It is with great pleasure that we announce the addition of containerised, turn-key solutions to our NEL A-range electrolysers. The existing NEL A-range are already recognised as the benchmark in energy efficiency. The containerised configuration brings a new level of innovative turn-key design, combined with unparalleled efficiency, practical design that enables quick and simple installation and the most compact solution offered in the market today”, says Jon Andre Løkke, CEO of Nel. The new configurations – Nel C-150 and Nel C-300 – are containerised and will be offered in addition to the existing industrial NEL A-range of electrolysers. The new products will have an output capacity of either 150 and 300 Nm3/hr respectively, which is equivalent to about 330 or 660 Kg/day. The standard gas output pressure will be 200 bar, which makes these products ideal for producing renewable hydrogen integrated with hydrogen fueling stations for cars, busses or other utility vehicles. “With these new products, the customer only need to push a button after connecting electricity and water. The new low-cost, turn-key solutions offer everything of our existing NEL A technology, with its proven reliability and robustness, but with added flexibility and ease-of-use. This is hydrogen production technology second to none,” says Løkke. ENDS For additional information, please contact: Jon André Løkke, CEO, +47 90 74 49 49 Bjørn Simonsen, VP Market Development and Public Relations, + 47 97 17 98 21 About Nel Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today.

NetEnt unveils hidden world of wonder with Secrets of Atlantis launch

Its subaquatic design delights include vibrant sea creatures and an alluring mermaid, on a 5-reel, 4-row, 40-line video slot platform perfected to entice players into its awe-inspiring world. Highlights, nudge wilds, colossal symbol re-spins and win both way features all add to the wondrous NetEnt graphics and ensure players an exciting gaming experience. Simon Hammon, Chief Product Officer of NetEnt, comments: “NetEnt delivers innovative game themes designed to attract players and keep them coming back for more. Now they’ll be able to get submerged in this stunning slot which once again shows why NetEnt is at the head of the market when it comes to casino games.”  View game demo ( For additional information please contact:Simon Hammon, Chief Product Officer NetEnt, Phone +356 2276 8145simon.hammon@netent.comMarianne Eklund, PR Manager NetEnt, Phone +46 760 024  About NetEnt  NetEnt AB (publ) is a leading digital entertainment company, providing premium gaming solutions to the world’s most successful online casino operators. Since its inception in 1996, NetEnt has been a true pioneer in driving the market with thrilling games powered by their cutting-edge platform. With innovation at its core, NetEnt is committed to helping customers stay ahead of the competition. NetEnt is listed on Nasdaq Stockholm (NET-B), employs 750 people and has offices in Stockholm, Malta, Kiev, Gothenburg, New Jersey, Krakow and Gibraltar. 

Strong performance and profitable growth for Rovio in first half of 2016

Rovio Entertainment has grown profitably in the first half of 2016, even before the profits from the blockbuster Angry Birds Movie have hit the books. The company earned 76,4 mEUR in revenue in the first half, a 10,3 mEUR year-on-year improvement, finishing the first half with an EBIT result of 5,7 mEUR, a 15,9 mEUR improvement over the same period last year. Rovio’s games business is thriving with year-on-year revenue growth of 24 per cent. Rovio’s animation business saw the globally successful theatrical release of The Angry Birds Movie, which opened in the No. 1 position in 52 countries, including the massive Chinese and U.S. markets. The Angry Birds Movie has so far grossed more than 347 million dollars at the box office globally. The movie will open in Japan October 1. “With the excellent performance of our games portfolio and the fantastic movie, the Angry Birds brand is flying high and we are seeing positive EBIT and cash flow development, while fulfilling our mission to create world class entertainment,” says CEO Kati Levoranta. “We currently have several exciting new games and other projects in development, including new IP, and we have started planning the sequel to The Angry Birds Movie.” The Angry Birds Movie was released digitally in selected Asian markets and North America on July 29, where it quickly went to No. 1 on iTunes, followed by DVD and Blu-ray releases on August 16. The in-home release of the film in other countries and territories continues to roll out in the weeks ahead, with most of Europe seeing the in-home release in September.

ASSA ABLOY on Forbes’ list of the world’s 100 most innovative companies

ASSA ABLOY, the global leader in door opening solutions, has for the third time been ranked in Forbes’ list of the world’s most innovative companies 2016. “I’m very pleased that we have achieved such success with our R&D,” says Johan Molin, President and CEO of ASSA ABLOY. "Over the past ten years ASSA ABLOY has invested heavily in innovation, with the goal of doubling the innovation rate and the target that products launched within the past three years should account for at least 25 percent of sales. Today this target has been achieved, with a share of 31 percent of our sales from new products”. ASSA ABLOYs R&D investments have increased by 230 percent since 2005, and today the Group has more than 1 800 development engineers. ASSA ABLOYs ambition is to be the industry’s most innovative company. The full list is available at:  For more information, please contact:Johan Molin, President and CEO, tel. no: +46 8 506 485 42Carolina Dybeck Happe, CFO and Executive Vice President, tel. no: +46 8 506 485 72 About ASSA ABLOYASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end‑user needs for security, safety and convenience. Since its formation in 1994, ASSA ABLOY has grown from a regional company into an international group with about 46,000 employees, operations in more than 70 countries and sales of SEK 68 billion. In the fast-growing electromechanical security segment, the Group has a leading position in areas such as access control, identification technology, entrance automation and hotel security.

Nordea and DNB to combine Baltic operations

Nordea and DNB have entered into an agreement to combine their operations in Estonia, Latvia and Lithuania to create a leading main bank in the Baltics with strong Nordic roots. “Combining knowledge of the Baltic market, close cooperation with our customers and developments in digital banking, Nordea has over the years built a solid and successful bank in the Baltic region with a strong position as number three in the Baltics. Now it is time to take the next step and build for the future. Together we will have the scale, stronger geographic presence and broader product offering enabling us to become the main bank for customers in the Baltics,” says Inga Skisaker, Head of Banking Baltic Countries, Nordea. Nordea’s and DNB’s operations in the Baltics are a great match, with complementary lines of business. Nordea has built a strong position within the large corporate segment whereas DNB is strong in the SME segment. Together, the banks will also have an even larger and more competitive retail business. Furthermore, the combined bank will have a strong geographic presence, with Nordea’s strong Estonian, DNB’s strong Lithuanian and jointly strong Latvian footprints. Nordea’s and DNB’s Baltic operations have 1,300 and 1,800 employees and EUR 8 billion and EUR 5 billion in assets[1], respectively. “With over 70 branches in the Baltics, DNB have created a dynamic and customer-centric operation. Scale is key in banking today, with larger banks having more efficient use of resources. The new bank will be better equipped to counter increasing competition in the region and capitalise on scale in order to become the main bank for more businesses, customers and partners in the Baltics,” says Mats Wermelin, Head of Baltic Division, DNB. Nordea and DNB will have equal voting rights over the combined bank, while having different economic ownership levels that reflect the relative equity value of their contribution to the combined bank at the time of closing. The transaction is conditional upon regulatory approvals and conditions, and is expected to close around Q2 2017. The banks will operate independently until all necessary approvals have been received.  [1] Based on loans and receivables to the public With regard to the announcement we invite you to a press meeting. Inga Skisaker, Head of Banking Baltic Countries, Nordea and Mats Wermelin, Head of Baltic Division, DNB will participate.   Time: Thursday 25 August 11.30 CET (12.30EET). For security reasons, a valid identity card is required. To attend the press conference, please e-mail Signe Lonerte,, +371 2911 6146.   Place: The Radisson Blu Hotel Latvija, Elizabetes 55, Riga, LatviaThe press conference will be conducted in English.  For further information:   Nordea:Signe Lonerte, Head of Communication Baltic Countries, Nordea, +371 29 11 61 46, signe.lonerte@nordea.comMagnus Nelin, Chief Press Officer, Sweden, Nordea, +46 721 45 26 40, DNB:Thomas Midteide, Group Executive Vice President, Corporate Communications, DNB, +47 962 32 017,   About Nordea Nordea is among the ten largest universal banks in Europe in terms of total market capitalisation and has around 11 million customers, 30,000 employees and approximately 600 branch office locations. The Nordea share is listed on the Nasdaq Stockholm, Nasdaq Helsinki and Nasdaq Copenhagen exchanges. We have a broad expertise across the wide range of products, services and solutions that we provide within banking, asset management and insurance. In Nordea we build trusted relationships through our strong engagement with both customers and society. About DNB  DNB is Norway's largest financial services group and one of the largest in the Nordic region in terms of market capitalization. The Group offers a full range of financial services, including loans, savings, advisory services, insurance and pension products for retail and corporate customers. DNB is a major operator in a number of industries, for which we also have a Nordic or international strategy. DNB is one of the world’s leading shipping banks and has a strong position in the energy sector, and the fisheries and seafood industry.

NetEnt launches games with The Rank Group Plc

The Rank Group Plc is one of the largest gaming companies in Europe with a strong market presence in the UK and with well-known brands such as Grosvenor Casinos ( and Mecca ( For more information about the agreement with Rank Group, please see the press release from June 2016: For additional information please contact:Enrico Bradamante, MD of NetEnt Malta Ltd and Chief of European Market Operations Phone: +356 79 676 Roland Glasfors, Investor Relations, NetEnt AB (publ)Phone +46 760 024 This information is information that NetEnt AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:30 CET on August 25, 2016. About NetEntNetEnt AB (publ) is a leading digital entertainment company, providing premium gaming solutions to the world’s most successful online casino operators. Since its inception in 1996, NetEnt has been a true pioneer in driving the market with thrilling games powered by a cutting-edge platform. NetEnt is committed to helping customers stay ahead of the competition, is listed on NASDAQ Stockholm (NET–B) and employs 800 people in Stockholm, Malta, Kiev, Krakow, Gothenburg, Gibraltar and New Jersey.

Environmental pioneer Viking Grace marks 1,000 LNG bunkerings

One thousand bunkerings via the M/S Seagas The M/S Seagas, which was specially built for ship-to-ship refuelling, has performed its 1,000th LNG bunkering of the Viking Grace since that vessel was placed in service in January 2013. The Seagas supplies the Viking Grace with about 60 tonnes of LNG while the vessel is docked in the morning at Stadsgården in central Stockholm. The Seagas is the first vessel of its kind in the world and is classified according to the same regulations as for ocean-going LNG tankers. Viking Line’s wish was for bunkering to occur as quickly as possible, with no interruptions, with assured deliveries and without affecting cargo handling on the quay. With its safe LNG bunker solution using the Seagas, AGA could meet Viking Line’s needs. The safety aspect was also extremely important in this context. “We are really pleased about having used LNG to fuel the M/S Viking Grace”, says Jan Hanses, President and CEO of Viking Line Abp. “Both the technical solution developed by AGA and the vessel’s operation have outperformed expectations, and it is gratifying to note the major benefits for the workplace along with the environmental gains that running on LNG provides.”    “We are obviously delighted with the positive response we have had from Viking Line regarding the Seagas and our bunkering solution”, says Jonas Åkermark, who is in charge of the LNG marine market at AGA Gas AB. “There is still heavy interest in the Seagas, our ship-to-ship bunkering solution and LNG as a marine fuel both in Sweden and internationally. We have a well-functioning infrastructure solution in place in Stockholm and the possibility of bunkering more vessels.” Positive response In February 2012, Viking Line signed an agreement with AGA Gas AB for the delivery of liquefied natural gas (LNG) for its newly ordered passenger vessel the Viking Grace. With its strong environmental profile, the ship was a trailblazer in the marine industry, going into service less than a year later, in January 2013. There were many unanswered questions, including how the gas would actually be supplied to the vessel and the attitude of customers towards what, for them, was a new type of fuel. Among the steps it took to ensure it was well prepared, Viking Line put together factsheets about the properties of the gas. The company expected some degree of scepticism, but in retrospect the response was incredibly positive. Viking Line received a very favourable response to the fuel alternative it had chosen and for the environmental values that the Viking Grace represented. International attention also exceeded all expectations. For further information, please contact: Johanna Boijer-Svahnström, Vice President Corporate Communications,, +358 18 270 00 Kari Granberg, Project Head, Marine Operations,, + 358 18 270 00 Christa Grönlund, Communications Manager, Finland,, +358 9 123 5242 Eleonora Hansi, Communications Manager, Sweden,, 08-452 41 41 Jonas Åkermark, LNG Marine - Sales and Business Development Manager, AGA Gas ,+ 46-8-731 18 44  Film in swedish:

Finland’s largest media companies to launch a shared Automated Guaranteed marketplace

Press release 25 August 2016 at 10 a.m. FINLAND’S LARGEST MEDIA COMPANIES TO LAUNCH A SHARED AUTOMATED GUARANTEED MARKETPLACE Ten Finnish media companies (Sanoma Corporation, Alma Media Corporation, Otavamedia Ltd, Aller Media Oy, A-lehdet Oy, MTV Oy, KSF Media Ab, Kaleva365 Oy, Improve Media Oy and Keskisuomalainen Oyj) will launch a shared Automated Guaranteed marketplace in autumn 2016. The marketplace makes it easier and faster for media agencies to plan and buy digital advertising. The marketplace covers desktop, mobile and video advertising products. - It’s great to see Finnish media companies joining forces and launching a shared tool for Automated Guaranteed buying. For quite some time now, there’s been a need for a controlled and fast process for reserving and buying digital advertising. We and other media agencies are eagerly looking forward to using this new tool. It represents a positive step forward that we have been hoping to see, says Antti Kallio, Director of Technology at media agency Dagmar. Digital advertising can be bought in an automated manner either as an Automated Guaranteed transaction or by Real Time Bidding. Buying guaranteed campaigns has been a largely manual process. The Automated Guaranteed solution automates the buying process, thereby significantly reducing the work phases involved in booking campaigns with guaranteed impressions. - Our goal is to make it easier and more efficient to buy media space. Many of the tools are still in the development phase globally, so it is great to see Finnish media companies and agencies promoting progress in automated buying, says Johanna Vartiainen, Director of Digital Ad Operations and Development at Alma Media. - We are pleased to work together to introduce a tool here in Finland that ensures the competitiveness of Finnish media in the digital market, adds Hans Edin, Chief Commercial Officer at Sanoma Media Finland. The media companies have selected Adform A/S, a company that specialises in digital advertising solutions, as their shared system provider. Adform has operated in Finland since 2012 and it provides a comprehensive range of online advertising tools for advertising buyers as well as sellers. Adform’s development resources provide a strong foundation for the development of the new system and its launch in the media market. The shared Automated Guaranteed marketplace will simplify advertising buying processes by making it possible to buy digital advertising products from Finland’s largest media companies through a single tool. The service allows buyers to select suitable media and products, check the availability of impressions, negotiate prices, reserve ad placements and submit campaign materials directly to the publishers’ ad servers. Buyers will also be able to monitor the progress of their campaigns through the service. In 2015, 85 per cent of digital advertising campaigns in Finland were bought with traditional guaranteed impressions. In recent years, digital advertising as a whole has quickly risen to become the largest category of advertising. Investments in digital advertising exceeded the print advertising volume for the first time in the first quarter of 2016. In 2015, digital advertising spending in Finland amounted to MEUR 286.1. For more information, please contact: Alma Media, Johanna Vartiainen, tel. +358 50 514 1952Sanoma Media Finland, Timo Rinne, tel. +358 40 571 3634

Zinzino launches new product segment: Zinzino Skin Care

Zinzino AB (publ), one of the world's leading direct sales companies within the health products sector, will now launch Zinzino Skin Care as a completely new product segment. The first product launched under the new banner is Skin Serum – 24 hour youth formula. The launch will take place immediately in August on the US market and will be introduced to Europe in October. Skin Serum has been developed by Zinzino and is produced in Zinzino's own production facility, Faun Pharma located just outside of Oslo in Norway. In the USA, the facial skincare product segment is estimated to report turnover of around USD 5.5 billion in 2016. The European market at least matches that in the US. Skin Serum has become a highly attractive product within the Skin Care segment and Zinzino has identified substantial potential for its new product, which will contribute strongly to the company achieving its growth targets and ensuring customer satisfaction.   Zinzino believes that product development is one of the key success factors for increased growth and expansion. Both new products and the development of existing products represent opportunities for enhanced growth, and July saw us begin sales in 19 new territories, meaning the company is now recording sales throughout the entire EU.  – Thanks to our in-house research and development and the fact that we ourselves produce our products, we can be sure that we maintain an extremely high level of quality from start to finish, while simultaneously keeping production costs as low as possible. We are now represented in 33 countries, with a total population of almost one billion. Our potential market is enormous, and with the products we now have in our portfolio, I have full confidence that we will achieve our goals. Our customers and partners must have faith that there is no let up in our own development and be certain that we are offering the best possible products, says Dag Bergheim Pettersen, CEO of Zinzino.   Zinzino Skin Serum is an active formula which gives skin a youthful appearance. Zinzino Skin Serum moisturises and softens the skin, boosting elasticity and rejuvenation. It eliminates fine lines and reduces wrinkles. The serum has both short-term and long-term beneficial effects and is applied under day and night cream. In addition, Zinzino Skin Serum has a neutral scent meaning that it does not compete with other scented products.  For more information, please contact: Dag Bergheim Pettersen, CEO of Zinzino, Tel. no.: +47(0) 93 22 57 00For free to publish pictures, please contact: Anders Ekhammar, Tel. +46 (0) 707 462 579Certified Adviser: Erik Penser Bank                The information presented here is such that Zinzino AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on August 25, 2016. Zinzino AB (publ), which is listed on OMX First North, is a direct sales company focussing on health products. The company markets and retails products within two product lines: Zinzino Health, which focuses on long-term health and accounts for approx. 70 percent of sales, and Zinzino Coffee, which sells espresso machines and accessories. Zinzino has a market presence across the EU, Norway and Iceland, as well as in the USA and Canada. Zinzino offers eco-friendly products with a focus on quality, health and a sense of everyday luxury. The company's values are characterised by high quality, proximity to customers and active product development. Zinzino owns the Norwegian knowledge company BioActive Foods AS and the research and production unit Faun Pharma AS, which produces all of Zinzino Health's products and all protein products for Proteinfabrikken. Since 2005, Zinzino has been a general agent for the Franco-Belgian coffee house Rombouts & Malongo. Zinzino forecasts a turnover of SEK 500 million for 2016. The Group has a head office in Gothenburg, a factory in Oslo, and offices in Helsinki, Oslo, Riga and Jupiter, Florida, and employs approximately 100 people.

Earlier release of Interim Report for January - June 2016

Zinzino hereby announces that the company will present the publication of the interim report for the period of January - June 2016, Friday the 26th of August at 13:00.        For more information, please contact: Dag Bergheim Pettersen, CEO of Zinzino, Tel. no.: +47(0) 93 22 57 00 For free to publish pictures, please contact: Anders Ekhammar, Tel. +46 (0) 707 462 579 Certified Adviser: Erik Penser Bank The information presented here is such that Zinzino AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on August 25, 2016.     Zinzino AB (publ), which is listed on OMX First North, is a direct sales company focussing on health products. The company markets and retails products within two product lines: Zinzino Health, which focuses on long-term health and accounts for approx. 70 percent of sales, and Zinzino Coffee, which sells espresso machines and accessories. Zinzino has a market presence across the EU, Norway and Iceland, as well as in the USA and Canada. Zinzino offers eco-friendly products with a focus on quality, health and a sense of everyday luxury. The company’s values are characterised by high quality, proximity to customers and active product development. Zinzino owns the Norwegian knowledge company BioActive Foods AS and the research and production unit Faun Pharma AS, which produces all of Zinzino Health’s products and all protein products for Proteinfabrikken. Since 2005, Zinzino has been a general agent for the Franco-Belgian coffee house Rombouts & Malongo. Zinzino forecasts a turnover of SEK 500 million for 2016. The Group has a head office in Gothenburg, a factory in Oslo, and offices in Helsinki, Oslo, Riga and Jupiter, Florida, and employs approximately 100 people.